gadolinium has been researched along with Benign Neoplasms in 269 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.37) | 18.7374 |
| 1990's | 12 (4.46) | 18.2507 |
| 2000's | 38 (14.13) | 29.6817 |
| 2010's | 156 (57.99) | 24.3611 |
| 2020's | 62 (23.05) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, Y; Guo, Q; Li, C; Li, J; Li, X; Su, L; Wu, M; Wu, X; Xiao, Z; Zhang, X | 1 |
| Cai, W; Dong, J; Guo, C; Song, B; Sun, J; Zhang, R; Zhao, X | 1 |
| Bendszus, M; Brandes, AA; Brugnara, G; Debus, J; Foltyn, M; Gorlia, T; Heiland, S; Idbaih, A; Isensee, F; Jayachandran Preetha, C; Kessler, T; Mahmutoglu, MA; Maier-Hein, KH; Meredig, H; Nabors, B; Neuberger, U; Petersen, J; Pflüger, I; Platten, M; Schell, M; Stupp, R; Tonn, JC; van den Bent, MJ; Vollmuth, P; Weller, M; Wick, A; Wick, W; Winkler, F | 1 |
| Chang, L; Liu, S; Meng, X; Plant, LD; Su, J; Wang, X; Wu, C; Yang, N | 1 |
| Ahmad, MY; Chae, KS; Chang, Y; Ho, SL; Kim, S; Lee, GH; Liu, S; Liu, Y; Nam, SW; Park, JA; Saidi, AKAA; Tegafaw, T; Yue, H; Zhao, D | 1 |
| Arnaud, F; Cadour, F; Cautela, J; Habert, P; Jacquier, A; Lalevée, N; Meilhac, A; Paganelli, F; Rapacchi, S; Scemama, U; Thuny, F; Varoquaux, A | 1 |
| Bao, J; Cheng, J; Fan, D; Guo, S; Ji, Z; Pang, X; Shi, Y; Zhang, Y; Zhuang, Y; Zu, X | 1 |
| Blum, NT; He, T; Huang, P; Lei, S; Lin, J; Qu, J; Zhang, J; Zhao, F | 1 |
| Grebowski, J; Litwinienko, G | 1 |
| Du, L; Feng, L; Gu, Y; He, N; Ji, K; Liu, Q; Liu, Y; Song, H; Sun, H; Tillement, O; Wang, J; Wang, Q; Wang, W; Wang, Y; Xu, C; Zhang, M; Zhang, Y | 1 |
| Chang, Y; Kim, JY; Kim, KW; Lee, W; Lim, JE; Sarkar, S; Yoo, J | 1 |
| Audhya, A; Brunnquell, CL; Choi, C; Clark, PA; Grudzinski, JG; Hernandez, R; Jeffrey, J; Kuo, JS; McMillan, AB; Pinchuk, AN; Weichert, JP; Zhang, RR | 1 |
| Laney, V; Li, Y; Lu, ZR | 1 |
| Cao, J; Cao, Y; Hao, L; Luo, Y; Qiao, B; Ran, H; Ren, J; Wang, Z; Xiang, Q; Xie, Z; Yang, A; Yang, C; Zhang, P; Zhou, Z | 1 |
| Hama, Y; Tate, E | 1 |
| Cai, H; Doussineau, T; Du, L; Feng, L; Gu, Y; He, N; Ji, K; Leduc, G; Liu, Q; Liu, Y; Lux, F; Song, H; Sun, H; Sun, X; Tillement, O; Wang, J; Wang, Q; Wang, Y; Xie, Y; Xu, C; Zhai, H; Zhang, M | 1 |
| Li, L; Ma, C; Wang, Y; Wu, Y; Yu, J; Zhang, LW; Zhang, S | 1 |
| Tamanoi, F; Yoshikawa, K | 1 |
| Balcioglu, E; Charmi, J; Ertas, YN; Ghaffarlou, M; Nosrati, H; Salehiabar, M; Yaray, K | 1 |
| Liang, G; Tian, C; Wang, C; Wang, L; Wang, Y; Wei, M; Wu, C; Yuan, Y; Zhang, T | 1 |
| He, J; Hou, D; Jiang, Y; Li, Y; Li, Z; Liang, X; Liu, P; Liu, S; Rong, H; Wang, D; Wang, Y; Yi, Y; Zhang, J | 1 |
| Li, S; Li, W; Liang, H; Man, X; Xu, G; Yang, F; Yang, T; Zhang, Z | 1 |
| Chen, M; Chong, L; He, C; Li, J; Song, X; Wang, D; Xing, M; Zhang, C; Zhang, X | 1 |
| Brilli, F; Catapano, F; Figliozzi, S; Francone, M; Lisi, C; Lo Monaco, M; Monti, L; Rondi, P | 1 |
| Osman, AFI; Tamam, NM | 1 |
| Kanamori, M; Kayano, S; Mugikura, S; Nemoto, H; Saito, R; Shimoda, Y; Shingai, Y; Tominaga, T | 1 |
| Baker, RW; Hall, AJ; Hill, LR; Rendina, LM; Robertson, AG | 1 |
| Chen, J; Cheng, MHY; Gao, Y; Li, X; Liang, X; Luo, Q; Ma, X; Shi, J; Sun, Y; Wang, F; Yao, M; Yu, Y; Zheng, G | 1 |
| Ainaya, Q; Anufriev, SA; Nakamura, H; Nishimura, K; Okada, S; Sakurai, Y; Shiraishi, K; Sivaev, IB; Suzuki, M; Yokoyama, M | 1 |
| Baltzer, PAT; Furtner, J; Hojreh, A; Krall, C; Mulabdic, A; Peyrl, A; Pogledic, I | 1 |
| Devreux, M; Henoumont, C; Laurent, S | 1 |
| Aryal, S; Marasini, R; Thanh Nguyen, TD | 1 |
| Feng, Q; Jiang, X; Li, X | 1 |
| Dong, J; He, C; Liu, L; Ma, D; Shao, Y; Wu, H; Xu, F; Yang, R; Yin, J; Zhang, Y | 1 |
| Catala, L; Fétiveau, L; Gazeau, F; George, R; Gloter, A; Laurent, S; Mejanelle, P; Muller, R; Nicolas-Boluda, A; Paul, G; Sancey, L; Volatron, J | 1 |
| Alam, NR; Gholibegloo, E; Haghgoo, S; Khoobi, M; Mesbahi, A; Mortezazadeh, T | 1 |
| Crawford, D; Gräfe, JL; Khan, R; Van Delinder, KW; Zhang, T | 1 |
| Chen, W; Gu, Y; Shi, B; Yan, F; Yan, J; Ye, J; Zhang, B; Zhang, H; Zhang, Y; Zheng, C | 1 |
| Bort, G; Crémillieux, Y; Dufort, S; Lux, F; Tillement, O; Verry, C | 1 |
| Gai, S; Gulzar, A; He, F; Wang, Z; Yang, D; Yang, P; Zhang, F | 1 |
| Fan, Z; Ge, D; Han, J; Hou, Z; Huang, D; Jiang, B; Su, G; Tu, L; Xiang, S; Yang, Y; Zhao, Q; Zhu, Q | 1 |
| Bu, W; Cheng, H; Gong, T; Liu, Y; Meng, X; Wang, B; Wang, H; Yang, W; Yao, Y; Yi, Y; Zhang, B | 1 |
| Achten, R; Alhendal, A; Bhaduri, S; Husain, AA; Mouffouk, F; Serrai, H; Seyyedhamzeh, M; Zourob, M | 1 |
| Fuentealba, M; Santibáñez, M | 1 |
| Gao, C; Kwong, CHT; Lee, SMY; Li, Z; Lu, S; Sun, C; Wang, R; Yang, YW | 1 |
| Ito, A; Li, X; Wang, X | 1 |
| Li, B; Wan, G; Wu, L; Zhou, T | 1 |
| Li, Q; Si, Y; Tian, G; Wang, B; Wu, Z; Xiao, J; Xing, X; Xu, R; Xu, Z; Zhang, G; Zhu, L | 1 |
| Bo, R; Jia, B; Li, L; Li, Y; Lin, TY; Lindstrom, A; Louie, AY; Ma, Z; Qu, H; Ricci, M; Vapniarsky, N; Wu, H; Xiao, W; Xue, X; Yuan, Y; Zhang, D; Zhu, Z | 1 |
| Galons, JP; Korn, RL; Lorza, AMA; Parra, NA; Philip, RC; Raghunand, N; Ravi, H; Read, WL; Tibes, R; Trouard, TP; Von Hoff, DD | 1 |
| Gong, Q; Gu, Z; Li, H; Luo, K; Zeng, Y; Zhang, H | 1 |
| Gao, K; Gao, R; Shi, X; Xiong, S | 1 |
| Athwal, PSS; Blaes, AH; Chen, KA; Hooks, M; Joppa, S; Modi, K; Nijjar, PS; Okasha, O; Shenoy, C; Velangi, PS | 1 |
| He, XW; Li, S; Li, WY; Ren, XH; Wang, HY; Zhang, YK | 1 |
| Hu, Y; Huang, Z; Wang, Y; Wu, J; Yao, D; Yuan, A | 1 |
| Rendina, LM; Robertson, AG | 1 |
| Arib, C; Boumati, S; Djaker, N; Doan, BT; Khan, M; Spadavecchia, J; Thierno Diallo, A | 1 |
| Anemone, A; Consolino, L; Irrera, P; Longo, DL; Romdhane, F | 1 |
| Balcaen, L; Bolea-Fernandez, E; Braeckmans, K; Brans, T; De Rooster, H; De Smedt, SC; De Wever, O; Descamps, B; Devriendt, N; Fraire, JC; Harizaj, A; Lentacker, I; Mangodt, C; Roman, B; Stevens, CV; Stoppa, A; Stremersch, S; Vanhaecke, F; Vanhove, C; Willaert, W | 1 |
| Guo, X; Liu, Y; Mou, J; Tian, Y; Wang, L; Wu, H; Yang, S | 1 |
| Chang, Y; Jung, KH; Kim, JY; Lee, W; Lee, YJ; Park, JA; Yoo, J | 1 |
| Dai, Y; Gong, Q; Guo, S; Li, Z; Luo, K; Luo, Q; Wang, X; Ye, Y; Zhang, H | 1 |
| Cao, C; Hu, Z; Shi, X; Tian, J; Zhang, Z | 1 |
| Chen, Y; Shen, Y; Xiang, H; Zhang, J; Zhuang, S | 1 |
| Chang, TY; Hsieh, HH; Hsu, MH; Lin, JJ; Lin, MC; Peng, SL; Wu, CC; Wu, CY | 1 |
| Gao, X; Jia, Y; Luo, Y; Wang, Y; Xu, C; Zhang, C | 1 |
| Ding, Y; Hu, A; Li, Y; Qian, W; Qiu, Z; Tang, W; Wang, J; Yuan, Z; Zhu, Q | 1 |
| Apih, T; Bahnemann, DW; Boschloo, G; Dillert, R; Drobne, D; Edvinsson, T; Iglič, A; Imani, R; Kononenko, V; Kralj-Iglič, V; Pazoki, M; Repar, N | 1 |
| Borowsky, AD; Curry, FE; Ferrara, KW; Fite, BZ; Foiret, JL; Ingham, ES; Kheirolomoom, A; Mahakian, LM; Seo, JW; Tam, SM | 1 |
| Hwang, C; Kim, J; Kim, JM | 1 |
| Fan, F; Gao, M; Liu, J; Qian, H; Sun, T; Tao, W; Yang, X; Yu, Y; Zhang, H; Zhong, F | 1 |
| Greer, MC; States, LJ; Voss, SD | 1 |
| Hill, MA; Morrison, RA; Rybak-Smith, MJ; Thiebaut, B; Thompson, JM; Townley, HE | 1 |
| Han, G; Huang, K; Huang, L; Jiang, N; Li, H; Li, J; Niu, Y; Peng, J; Yang, J; Zhang, X; Zhao, Y; Zheng, S | 1 |
| Dong, L; Du, W; Hai, Z; Liang, G; Qian, J; Xu, J; Zhong, K | 1 |
| Dong, X; Du, J; Gu, Z; Guo, Z; Liu, X; Xie, J; Yong, Y; Zhang, C; Zhang, G; Zhao, Y | 1 |
| Ahn, M; Bang, JK; Bang, WY; Han, EH; Jin, SM; Kim, I; Ko, E; Lee, E | 1 |
| Chen, ML; Chen, XM; Li, L; Pang, SC | 1 |
| Balalaeva, IV; Gavrina, AI; Grigoryev, IS; Klapshina, LG; Lermontova, SA; Muravieva, MS; Shirmanova, MV; Yuzhakova, DV; Zagaynova, EV | 1 |
| Dong, L; Hao, LN; Li, F; Liu, K; Lu, Y; Qian, HS; Song, YH; Su, Y; Tao, W; Wu, YD; Xu, YJ; Yan, X; Yang, XZ; Zhou, W | 1 |
| Cheng, Y; Li, N; Liu, L; Song, Y; Sun, Q; Tan, F; Wang, J; Wang, S; Wang, Y; You, Q; Yu, M | 1 |
| Barnes, SL; Hormuth, DA; Quarles, CC; Sorace, AG; Woodall, RT; Yankeelov, TE | 1 |
| Aboagye, EO; Carroll, L; Cowell, S; Lavdas, I; Vilar, R | 1 |
| Chang, Y; Kim, HK; Lee, GH | 1 |
| Bibb, JA; Boada, C; Carter, AM; Cooke, JP; De Rosa, E; Evangelopoulos, M; Hartman, KA; Kirui, D; Martinez, JO; Molinaro, R; Sukhovershin, R; Tasciotti, E; Zhang, S | 1 |
| Chen, S; Jiang, C; Li, B; Liu, F; Ouyang, YH; Xu, W; Yan, GP; Yang, L; Zhou, CK | 1 |
| Amrahli, M; Centelles, MN; Gedroyc, W; Miller, AD; So, PW; Stebbing, J; Thanou, M; Wright, M; Xu, XY | 1 |
| Lux, J; Sherry, AD | 1 |
| Cao, Y; He, Y; Kuang, Y; Liu, M; Mao, Z; Pei, R; Xiong, D; Zu, G | 1 |
| Han, HY; Han, K; Ma, ZY; Mu, YL; Zhang, J | 1 |
| Bambery, K; Chacon, A; Franklin, DR; Gregoire, MC; Guatelli, S; Rosenfeld, A; Safavi-Naeini, M | 1 |
| Du, B; Ma, L; Wang, L; Weng, W; Xin, C; Yang, W; Yao, X | 1 |
| Chen, S; Hwang, DW; Li, H; Liu, M; Xie, J; Yang, Y; Yuan, Y; Zhang, A; Zhang, Z; Zhou, X | 1 |
| Chen, Y; Li, N; Pan, W; Tang, B; Wang, J; Yu, L; Zhang, X | 1 |
| Ali, SO; Fessas, P; Gallagher, FA; Graves, MJ; Houston, G; Kaggie, JD; Reid, S; Zaccagna, F | 1 |
| Dai, Y; Fan, Q; Li, M; Ma, W; Shen, Q; Su, J; Sun, P; Wang, B; Wang, Q; Wu, K | 1 |
| Chen, X; Chen, ZY; Fu, X; Jacobson, O; Liu, Y; Shen, Z; Wang, S; Wang, Z; Zhou, Z | 1 |
| Gao, J; Huang, J; Li, A; Lin, H; Richmond, J; Sun, C; Yang, Z | 1 |
| Aime, S; Baroni, S; Hu, H; Steinmetz, NF; Yang, H; Yang, Q | 1 |
| Dai, Y; Gong, Q; Hu, J; Li, H; Luo, K; Luo, Q; Wang, Y; Wei, X; Wu, J; Xiao, X | 1 |
| Henoumont, C; Hequet, E; Laurent, S; Muller, RN | 1 |
| Chen, L; Chen, Z; Gu, Z; Li, J; Su, H; Yan, L; Zhang, A; Zhao, F; Zhao, Y | 1 |
| He, H; Huang, W; Li, L; Liu, H; Shao, Y; Shen, Y; Tian, X | 1 |
| Antoine, R; Besse, S; Chezal, JM; Dugourd, P; Janier, M; Kryza, D; Lux, F; Mignot, A; Miot-Noirault, E; Morlieras, J; Perriat, P; Redini, F; Sancey, L; Tillement, O; Truillet, C; Vidal, A | 1 |
| Cheng, W; Chuang, KH; Liu, Y; Ping, Y; Zhang, Y | 1 |
| Li, Z; Liu, Z; Qu, X; Ren, J; Yang, X; Yin, M | 1 |
| Bu, W; Chen, F; Fan, W; He, Q; Liu, J; Ni, D; Peng, W; Shen, B; Shi, J; Xiao, Q; Xing, H; Zhang, S; Zhao, K; Zhou, L | 1 |
| He, X; Liu, F; Liu, L; Wang, Z; You, H; Zhang, H | 1 |
| Chang, JC; Chien, YH; Ho, HY; Ho, WY; Huang, CC; Hung, ST; Liau, MC; Su, CH; Yeh, CS | 1 |
| Alric, C; Bazzi, R; Billotey, C; Janier, M; Kryza, D; Lux, F; Miladi, I; Perriat, P; Roux, S; Taleb, J; Tillement, O | 1 |
| Demachi, K; Dewi, N; Horiguchi, Y; Iyomoto, N; Kakimi, K; Morishita, Y; Nagasaki, T; Nagasaki, Y; Nakajima, J; Ono, M; Sakurai, Y; Sekino, M; Shinohara, A; Takahashi, H; Yanagie, H; Yokoyama, K; Zhu, H | 1 |
| Amanlou, M; Arabzadeh, AJ; Ardestani, MS; Delbaz, SA; Ebrahimi, SE; Javidi, A; Mahian, H; Rad, AM | 1 |
| Heo, J; Jeon, H; Kim, D; Kim, S; Koh, J; Kwon, IC; Lee, KE; Lim, CK; Singh, A | 1 |
| Dai, Z; Liang, X; Yue, X; Zha, Z; Zhang, S | 1 |
| Liu, Y; Yu, D; Zhang, L; Zhangl, N | 1 |
| Liu, ZJ; Song, XX; Tang, Q | 1 |
| Huang, CH; Nwe, K; Tsourkas, A | 1 |
| Cugini, C; Dorigo, A; Fusaro, M; Morana, G; Scatto, G; Zanato, R | 1 |
| Chang, Y; Jung, JC; Jung, KH; Kang, MK; Kang, SH; Kim, HK; Kim, TJ; Kim, YH; Lee, GH | 1 |
| Shokrollahi, H | 1 |
| Dai, Y; Gai, S; He, F; Lv, R; Niu, N; Yang, P | 1 |
| Ananta, JS; Coughlin, AJ; Decuzzi, P; Deng, N; Larina, IV; West, JL | 1 |
| Gu, Z; Hu, Z; Jin, S; Liu, X; Ren, W; Tian, G; Yan, L; Yin, W; Zhang, X; Zhao, Y; Zhou, L | 1 |
| Chandrasekharan, P; Chuang, KH; He, T; Poh, Z; Raju, A; Robins, EG; Yang, CT | 1 |
| Chen, YY; Dai, YL; Li, CX; Lin, J; Ma, PA; Wu, Y; Yang, DM | 1 |
| Gallo, J; Long, NJ; Minuzzi, F; Rivas, C; Rutter, GA; Stasiuk, GJ | 1 |
| Cescato, R; Gmeiner, P; Hübner, H; Kolesinska, B; Maschauer, S; Prante, O; Purkayastha, N; Reubi, JC; Seebach, D; Sparr, C; Waser, B; Yoshinari, T | 1 |
| Aitken, JB; de Jonge, MD; Harris, HH; Ioppolo, JA; Morrison, DE; Rendina, LM | 1 |
| Cardiff, RD; Ferrara, KW; Fite, BZ; Gagnon, MK; Ingham, ES; Kheirolomoom, A; Mahakian, LM; Paoli, EE; Tam, S; Zhang, H | 1 |
| Kawano, K; Maitani, Y; Nakamura, T; Shiraishi, K; Yokoyama, M | 1 |
| Araya-Secchi, R; Huynh, T; Kang, SG; Wang, B; Wang, D; Zhou, R | 1 |
| Cohen, SM | 1 |
| Choi, Y; Haam, S; Han, S; Huh, YM; Jang, E; Kang, B; Lee, K; Lim, EK; Suh, JS | 1 |
| Dong, LX; Kong, D; Tang, SH; Wang, J; Yan, XP; Yang, CX | 1 |
| Gu, Z; Hu, Z; Ruan, L; Yang, Y; Yin, W; Zhang, X; Zhao, Y; Zheng, X; Zhou, L | 1 |
| Hu, R; Liu, L; Lv, F; Wang, B; Wang, S; Yuan, H | 1 |
| Barberi-Heyob, M; Berbeco, R; Bianchi, A; Boschetti, F; Butterworth, KT; Coll, JL; Crémillieux, Y; Denat, F; Detappe, A; Deutsch, E; Dufort, S; Dutreix, M; Fries, P; Janier, M; Kotb, S; Lacombe, S; Le Duc, G; Louis, C; Lux, F; McMahon, SJ; Perfettini, JL; Perriat, P; Porcel, E; Prise, KM; Rodriguez-Lafrasse, C; Roux, S; Sancey, L; Tillement, O; Verry, C | 1 |
| Banerjee, R; Díaz Díaz, D; Goswami, A; Kundu, T; Mitra, S; Patra, P | 1 |
| Chen, Q; He, J; Li, Y; Liang, C; Liu, Z; Wang, X | 1 |
| Aime, S; Guo, Z; Li, T; Sadler, PJ; Wang, X; Zhu, Z | 1 |
| Feygelman, V; Latifi, K; Moros, EG; Zhang, DG; Zhang, GG | 1 |
| Aitken, JB; de Jonge, MD; Harris, HH; Issa, F; Morrison, DE; Rendina, LM | 1 |
| He, D; Liu, Q; Na, N; Ouyang, J; Yang, C; Zhao, Y | 1 |
| Chan, CF; Lan, R; Law, GL; Wong, KL; Wong, WK; Zhang, T | 1 |
| Wang, J; Wu, D; Wu, H; Yang, S; Yang, Y; Zhang, H; Zhang, Y; Zhou, Z | 1 |
| Abu-Salah, KM; Alrokayan, SA; Dornelles, DF; dos Santos, NR; Lopes, AD; Martins, J; Mouffouk, F; Rosa da Costa, AM; Sau, P; Simão, T | 1 |
| Bonvalot, S; Calugaru, V; Hérault, J; Le Tourneau, C; Magné, N; Thariat, J | 1 |
| Gong, A; Liang, H; Lu, G; Luo, S; Ma, X; Pan, Y; Ren, W; Wu, A; Zeng, L; Zhang, L | 1 |
| Du, Q; Gao, F; Huang, Z; Meng, X; Wang, L; Wu, Z; Yin, G | 1 |
| Chan, MH; Lin, HM | 1 |
| Chai, ZF; Chen, HQ; Feng, WY; Sun, BY; Wang, B; Wang, M; Zhao, LC; Zhao, YL; Zheng, LN | 1 |
| Bianchi, A; Crémillieux, Y; Lux, F; Roux, S; Sancey, L; Tillement, O | 1 |
| Carceller, F; Collins, DJ; d'Arcy, JA; Jerome, NP; Koh, DM; Leach, MO; Marshall, LV; Miyazaki, K; Moreno, L; Orton, MR; Pearson, AD; Wallace, T; Zacharoulis, S | 1 |
| Aime, S; Dastrù, W; Di Gregorio, E; Ferrauto, G; Lanzardo, S | 1 |
| Carney, CE; Harrison, VS; MacRenaris, KW; Meade, TJ; Waters, EA | 1 |
| Koch, B; Mishra, K; Prasad, R; Rai, M; Rai, SB; Singh, AK; Singh, SK | 1 |
| Chang, J; Chen, N; Fang, X; Gong, X; Guo, W; Tu, Y; Wang, S; Yang, W; Zhang, B | 1 |
| An, Q; Chen, C; Guo, J; Li, D; Liu, J; Wan, J; Wang, C; Yu, M | 1 |
| Cao, M; Chen, C; Kou, Y; Li, J; Li, Y; Liu, J; Wang, J; Wang, L; Wang, P | 1 |
| Cheng, L; Gong, H; Liu, Z; Shen, S; Yang, K; Yi, X; Yuan, C | 1 |
| Chi, K; Daldrup-Link, HE; Gawande, R; Klenk, C; Leung, JT; Luna-Fineman, S; McMillan, A; Owen, D; Quon, A; Sakamoto, KM; Tran, VT | 1 |
| Chen, J; Chen, Z; Chi, X; Gao, J; Liu, H; Sun, C; Wang, L; Zhou, Z | 1 |
| Chai, C; He, XW; Hong, ZY; Kong, XQ; Li, Q; Li, WY; Shen, W; Sun, TT; Zhang, F; Zhang, YK | 1 |
| Antoch, G; Beiderwellen, K; Bockisch, A; Buchbender, C; Forsting, M; Heusch, P; Kühl, H; Quick, HH; Ruhlmann, V | 1 |
| Cai, J; Cheng, D; Li, X; Liu, S; Shi, H; Su, H; Yang, Y; Zhang, C; Zhang, J; Zhang, L; Zhang, Y | 1 |
| Bai, R; Chen, C; Chen, Z; Dong, J; Liu, J; Liu, Y; Miao, Q; Sun, B; Tang, J; Wang, L; Zhao, Y; Zhou, H | 1 |
| Du, H; Guo, D; Wang, J; Yang, W; Yu, J; Zhang, B | 1 |
| Amani, A; Ghaemi, B; Karimi, R; Kharrazi, S; Mashinchian, O; Mousavi, T | 1 |
| Kohane, DS; Li, L; Li, M; Tong, R | 1 |
| Abe, M; Endo, M; Hayashi, N; Ito, I; Mitsuya, K; Miyakita, Y; Nakasu, S; Nakasu, Y; Narita, Y; Ohno, M | 1 |
| Bashir, MR; Bridges, MD; Hope, MD; Hope, TA; Nguyen, KL; Reeder, SB; Vasanawala, SS | 1 |
| Aime, S; Arena, F; Baroni, S; Boffa, C; Di Gregorio, E; Gianolio, E; Hu, H; Orio, L; Stefania, R | 1 |
| Pu, F; Xue, S; Yang, JJ | 1 |
| Detappe, A; Lux, F; Tillement, O | 1 |
| Chen, D; Guan, M; Guan, X; Han, H; Shu, C; Wang, C; Zhang, Y; Zhen, M; Zou, T | 1 |
| Mohana Roopan, S; Samuel, EJ; Titus, D | 1 |
| Biegun, AK; Eustache, P; Lacombe, S; Lux, F; Mowat, P; Porcel, E; Remita, H; Salado, D; Schlathölter, T; Stefancikova, L; Tillement, O; van Goethem, MJ | 1 |
| Alberti, D; Altieri, S; Boggio, P; Bortolussi, S; Crich, SG; Deagostino, A; Protti, N | 1 |
| Berbeco, R; Biancur, D; Detappe, A; Drane, P; Guieze, R; Kunjachan, S; Langer, R; Makrigiorgos, GM; Motto-Ros, V; Sancey, L; Tillement, O | 1 |
| Ke, H; Li, Z; Miao, Z; Wang, J; Yue, X | 1 |
| Bai, B; Cao, M; Chen, C; Ji, Y; Liu, J; Liu, Y; Miao, Q; Wang, J; Wang, L; Wu, X; Xu, Y; Zhao, Y | 1 |
| Bharatha, A; Montanera, WJ; Park, AL; Ray, JG; Vermeulen, MJ | 1 |
| Fan, TY; Gu, MJ; Han, NY; Li, KF; Liu, LS; Wang, H; Yang, ZJ; Zhang, LX; Zheng, ZZ | 1 |
| Cascella, M; Catalano, O; Cuomo, A; dell'Aprovitola, N; Filice, S; Fusco, R; Granata, V; Izzo, F; Petrillo, A; Schiavone, V | 1 |
| Erdogan, S; Torchilin, VP | 2 |
| Cao, Y; Chen, Y; Hong, S; Kuang, Y; Liu, M; Pei, R; Wang, J; Wang, Z; Zhang, K | 1 |
| Ding, C; Jin, Y; Li, C; Pu, K; Zhang, N; Zhu, Y | 1 |
| Cochrane, EJ; Collins, RC; Jones, S; Metcalf, S; Paley, MNJ; Reynolds, S; Tozer, GM | 1 |
| Cao, Y; Dong, J; Kuang, Y; Liu, M; Luo, L; Pei, R; Zhang, T; Zu, G | 1 |
| de Langen, AJ; Lubberink, M; Marcus, JT; van den Boogaart, VE | 1 |
| Chen, C; Fu, PP; Gao, X; Lao, F; Liang, XJ; Meng, J; Sun, B; Wang, PC; Xing, G; Yin, JJ; Zhao, Y | 1 |
| Jeong, EK; Kaneshiro, TL; Lu, ZR; Morrell, G; Parker, DL | 1 |
| Abolmaali, ND; Abramyuk, AM; Tokalov, SV; Zophel, K | 1 |
| Bell, JD; Kalber, T; Kamaly, N; Miller, AD; Thanou, M | 1 |
| Barboriak, DP; Paldino, MJ | 1 |
| Bufalino, D; Cerullo, N; Daquino, G | 1 |
| Arnopolskaya, AM; Khokhlov, VF; Kozlovskaya, NG; Kulakov, VN; Mitin, VN; Portnov, AA; Sheino, IN; Zaitsev, KN | 1 |
| Tweedle, MF | 1 |
| Ejnik, J; Foxley, S; Karczmar, GS; Makinen, MW; Martin, H; Mustafi, D; Peng, B; Zamora, M | 1 |
| Bell, JD; Bunch, J; Kalber, TL; Kamaly, N; McLeod, CW; Miller, AD; Pugh, JA | 1 |
| Huang, K; Montenegro, M; Nahar, S; Pradhan, A; Yan, K; Yu, Y | 1 |
| Cheng, Z; Thorek, DL; Tsourkas, A | 1 |
| Choi, K; Han, MH; Jeong, SY; Kim, K; Kwon, IC; Leary, JJ; Lee, SY; Nam, T; Park, K; Park, S; Song, IC; Yuk, SA | 1 |
| Batt, C; Chen, Y; Ethirajan, M; Goswami, L; Mazurchuk, R; Missert, JR; Pandey, RK; Patel, NJ; Spernyak, JA; Turowski, S; White, WH | 1 |
| Huang, Q; Li, C; Lu, W; Melancon, MP; Ng, C; Thapa, P; Zhou, D | 1 |
| Baeuerle, T; Bock, M; Braun, K; Dunsch, L; Pipkorn, R; Waldeck, W; Wiessler, M; Yang, S | 1 |
| Backes, WH; Douma, K; Hackeng, TM; Oostendorp, M; Post, MJ; van Zandvoort, MA | 1 |
| Deorukhkar, A; Diagaradjane, P; Gelovani, JG; Krishnan, S; Maru, DM | 1 |
| Chiang, CS; Hwang, KC; Lai, PD; Wang, PJ; Yuan, CJ | 1 |
| de Smet, M; Grüll, H; Heijman, E; Hijnen, NM; Langereis, S | 1 |
| Dai, A; Hu, H; Li, F; Shi, X; Sun, Y; Wu, D; Yang, H; Yang, S; Zhuang, Y | 1 |
| Hu, X; Li, X; Liu, S; Liu, T; Qian, Y; You, Y; Zhang, G | 1 |
| Hsieh, YK; Jiang, PS; Peng, HH; Sun, TY; Wang, CF; Yang, BS | 1 |
| Ashokan, A; Chandran, P; Koyakutty, M; Menon, D; Nair, S; Sasidharan, A | 1 |
| Hennink, WE; Huis In 't Veld, R; Kiessling, F; Lammers, T; Storm, G | 1 |
| Gambhir, SS; Grimm, J; Kircher, MF | 1 |
| Stanwix, H | 1 |
| Bhuniya, S; Hong, KS; Jung, JH; Kim, JS; Lee, H; Lim, YT; Noh, YW; Park, J | 1 |
| Ahmed, MM; Gupta, S; Papineni, RV; Patel, V; Stoyanova, R | 1 |
| Choi, KS; Choi, SY; Kim, YS; Seo, YJ; Yang, J | 1 |
| Dobson, PJ; Kim, J; Townley, HE | 1 |
| Botta, M; Campbell, F; Hailes, HC; Hart, SL; Kenny, GD; Lythgoe, MF; Tabor, AB; Tagalakis, AD; Villegas-Llerena, C; Welser, K | 1 |
| Ding, D; Hu, Y; Li, K; Liu, B; Liu, J; Ng, JC; Pu, KY; Tang, BZ; Wang, G | 1 |
| Chen, X; Liang, X; Meng, J; Zhao, Y | 1 |
| Alcantara, GB; Aloy, MT; Anselme-Bertrand, I; Armandy, E; Boulé, C; Burdin, B; Cottier, M; Epicier, T; Joly-Pottuz, L; Lux, F; Malchère, A; Mowat, P; Perriat, P; Pourchez, J; Rima, W; Rivoire, A; Rodriguez-Lafrasse, C; Roux, S; Sancey, L; Tillement, O | 1 |
| Oto, A; Reiser, MF; Schmid-Tannwald, C; Zech, CJ | 1 |
| Cao, CY; Li, L; Liang, GL; Shen, YY; Wang, JD | 1 |
| Bu, W; Hua, Y; Pan, L; Peng, W; Ren, Q; Shi, J; Wang, L; Xing, H; Zhang, K; Zhang, S; Zheng, X; Zhou, L | 1 |
| Aime, S; Cabella, C; Colombatto, S; Geninatti Crich, S; Gianolio, E; Maggioni, F | 1 |
| Baick, CH; Chiou, JY; Fruehauf, JP; Mehta, RS; Nalcioglu, O; Su, MY; Wang, J; Yu, H | 1 |
| Carlsson, J; Forssell-Aronsson, E; Glimelius, B | 1 |
| Büchert, M; Drevs, J; Hennig, J; Mross, K; Scheffler, K; Strecker, R | 1 |
| Coakley, T; Jay, M; Mumper, RJ; Oyewumi, MO; Yokel, RA | 1 |
| Dzik-Jurasz, A; Padhani, AR | 1 |
| Brown, J; Farooki, A; Narra, V | 1 |
| Culbertson, CN; Jevremovic, T; Wangerin, K | 1 |
| Lindner, LH; Peller, M; Reinl, HM; Schlemmer, M; Stahl, R | 1 |
| Chai, Z; Chen, C; Chen, Z; Fang, X; Gao, Y; Li, B; Li, Y; Ma, B; Meng, H; Sun, J; Tang, J; Wan, L; Wang, J; Xing, G; Ye, C; Yu, H; Yuan, H; Zhao, Y; Zhu, C | 1 |
| Amiji, MM; van Vlerken, LE | 1 |
| Erdogan, S; Hurley, J; Roby, A; Sawant, R; Torchilin, VP | 1 |
| Liu, J; Murata, K; Nitta, N; Ohta, S; Sonoda, A; Tabata, Y; Yamada, M; Yamamoto, M | 1 |
| Lu, ZR; Mohs, AM | 1 |
| Clément, O; Siauve, N | 1 |
| Backer, MM; Brindle, KM; Davletov, B; Hu, DE; Kettunen, MI; Krishnan, AS; Neves, AA | 1 |
| Huwart, L; Michoux, N; Van Beers, B | 1 |
| Frullano, L; Meade, TJ | 1 |
| Lu, ZR; Vaidya, A; Ye, F | 1 |
| Hartman, KB; Wilson, LJ | 1 |
| Viglianti, BL | 1 |
| Maruyama, Y; Porter, AT; Wierzbicki, JG | 1 |
| Byrne, MJ; Jackson, GE | 1 |
| Carvlin, MJ; Parker, JR; Yuh, WT | 1 |
| Akine, Y; Fukumori, Y; Ichikawa, H; Miyamoto, M; Tokuuye, K | 1 |
| Bradley, WG; Dietrich, RB; Goyal, AK; Kidney, DD; Yan, K | 1 |
| Bittner, R; Felix, R; Lang, P; Schörner, W | 1 |
| Jones-Bey, H | 1 |
| Block, LH; Fukumori, Y; Ichikawa, H; Tokumitsu, H | 1 |
| Aime, S; Botta, M; Crich, SG; Garino, E; Giovenzana, G; Pagliarin, R; Palmisano, G; Sisti, M | 1 |
| Goorley, T; Nikjoo, H | 1 |
| Becerra, CR; Carbone, DP; Frenkel, EP; Rosenthal, DI; Toto, RD | 1 |
| Heerschap, A; Joosten, FB; Kaanders, JH; Rijpkema, M; van der Kogel, AJ | 1 |
| Fukumori, Y; Ichikawa, H; Shikata, F; Tokumitsu, H | 1 |
| Blaum, K; Bushaw, BA; Geppert, C; Hengstler, JG; Müller, P; Nörtershäuser, W; Schreiber, WG; Wendt, K | 1 |
| Barzen, G; Felix, R | 1 |
| Matsumoto, T | 1 |
| Böcker, D; Drews, C; Erlemann, R; Peters, PE; Stöber, U | 1 |
| Fretz, C; Herschkowitz, N; Schuknecht, B; Terrier, F; Vock, P | 1 |
| Imhof, H; Kramer, J; Prayer, L; Stiglbauer, R; Wimberger, D | 1 |
44 review(s) available for gadolinium and Benign Neoplasms
| Article | Year |
|---|---|
Metallofullerenols in biomedical applications.
Topics: Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2022 |
Multimodality imaging in cardio-oncology: the added value of CMR and CCTA.
Topics: Computed Tomography Angiography; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Magnetic Resonance Spectroscopy; Myocardium; Neoplasms; Predictive Value of Tests; Ventricular Function, Left | 2023 |
Mn-Based MRI Contrast Agents: An Overview.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Manganese; Neoplasms | 2023 |
Integration of gadolinium in nanostructure for contrast enhanced-magnetic resonance imaging.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Nanostructures; Neoplasms; Theranostic Nanomedicine | 2020 |
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles.
Topics: Animals; Chelating Agents; Gadolinium; Humans; Nanoparticles; Neoplasms; Particle Size; Siloxanes; Theranostic Nanomedicine; Tissue Distribution | 2020 |
Functional gadolinium-based nanoscale systems for cancer theranostics.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Precision Medicine; Theranostic Nanomedicine | 2021 |
Gadolinium theranostics for the diagnosis and treatment of cancer.
Topics: Antineoplastic Agents; Gadolinium; Humans; Neoplasms; Precision Medicine; Theranostic Nanomedicine | 2021 |
Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI.
Topics: Adolescent; Early Detection of Cancer; Gadolinium; Genetic Predisposition to Disease; Humans; Magnetic Resonance Imaging; Neoplasms; Whole Body Imaging | 2017 |
Gadolinium as an MRI contrast agent.
Topics: Animals; Brain; Contrast Media; Coordination Complexes; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasms; Theranostic Nanomedicine | 2018 |
Advances in gadolinium-based MRI contrast agent designs for monitoring biological processes in vivo.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Zinc | 2018 |
Fluorinated MRI contrast agents and their versatile applications in the biomedical field.
Topics: Animals; Cell Tracking; Contrast Media; Dendrimers; Drug Delivery Systems; Fluorine; Fluorocarbons; Gadolinium; Halogenation; Humans; Magnetic Resonance Imaging; Neoplasms; Polymers | 2019 |
The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy.
Topics: Contrast Media; Coordination Complexes; Fullerenes; Gadolinium; Humans; Nanomedicine; Neoplasms; Neoplastic Stem Cells; Reactive Oxygen Species; Tumor Microenvironment | 2019 |
Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Neoplasms | 2013 |
Use of contrast agents in oncological imaging: magnetic resonance imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Contrast Media; Female; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasms; Perfusion Imaging | 2013 |
Contrast agents for MRI.
Topics: Contrast Media; Ferrosoferric Oxide; Gadolinium; Humans; Lanthanoid Series Elements; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Nanoparticles; Neoplasms; Particle Size | 2013 |
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Models, Theoretical; Nanoparticles; Neoplasms; Radiation-Sensitizing Agents; Siloxanes | 2014 |
[Nanoparticles and radiation therapy].
Topics: Gadolinium; Gold; Humans; Metal Nanoparticles; Neoplasms; Platinum; Radiation-Sensitizing Agents; Silver | 2015 |
Gadolinium-based nanoparticles for theranostic MRI-radiosensitization.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Radiography; Theranostic Nanomedicine; Tissue Distribution | 2015 |
Safety and technique of ferumoxytol administration for MRI.
Topics: Clinical Trials as Topic; Contrast Media; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Humans; Iodine; Macrophages; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasms; Patient Safety; Perfusion | 2016 |
Current scenario of biomedical aspect of metal-based nanoparticles on gel dosimetry.
Topics: Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Gadolinium; Gels; Gold; Hafnium; Humans; Iodine; Iron; Metal Nanoparticles; Nanotechnology; Neoplasms; Oxides; Platinum; Radiometry; Radiotherapy Dosage; Silver | 2016 |
Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
Topics: Boron; Gadolinium; Humans; Neoplasms; Neutron Capture Therapy | 2016 |
Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Polymers | 2018 |
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
Topics: Blood Flow Velocity; Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Neovascularization, Pathologic; Oxygen Radioisotopes; Positron-Emission Tomography; Water | 2008 |
Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
Topics: Biomarkers, Tumor; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Mathematics; Neoplasms; Neovascularization, Pathologic | 2009 |
Noninvasive cell-tracking methods.
Topics: Animals; Cell Movement; Cell Tracking; Contrast Media; Dendritic Cells; Gadolinium; Genes, Reporter; Humans; Immunotherapy, Adoptive; Luminescent Measurements; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Microscopy, Fluorescence; Models, Animal; Nanoparticles; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
A realistic utilization of nanotechnology in molecular imaging and targeted radiotherapy of solid tumors.
Topics: Animals; Annexin A5; Antineoplastic Agents; Contrast Media; Drug Carriers; Fluorescent Dyes; Fluorometry; Gadolinium; Humans; Molecular Imaging; Nanoparticles; Nanotechnology; Neoplasms; Organotechnetium Compounds; Positron-Emission Tomography; Quantum Dots; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Spectrum Analysis, Raman; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2012 |
Biological characterizations of [Gd@C82(OH)22]n nanoparticles as fullerene derivatives for cancer therapy.
Topics: Fullerenes; Gadolinium; Humans; Metal Nanoparticles; Nanocapsules; Neoplasms | 2013 |
Diffusion-weighted MRI of the abdomen: current value in clinical routine.
Topics: Adult; Aged; Cell Membrane; Contrast Media; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fibrosis; Gadolinium; Gastrointestinal Diseases; Humans; Intestines; Kidney; Liver; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Pancreas; Patient Safety | 2013 |
Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Structure-Activity Relationship | 2002 |
Radiation therapy through activation of stable nuclides.
Topics: Boron; Gadolinium; Glioma; Humans; Isotopes; Melanoma; Neoplasms; Neutron Capture Therapy | 2002 |
DCE-MRI in clinical trials: data acquisition techniques and analysis methods.
Topics: Angiogenesis Inhibitors; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Contrast Media; Data Collection; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasms; Radioisotopes; Radionuclide Imaging; Statistics as Topic | 2003 |
Perfusion MR imaging of extracranial tumor angiogenesis.
Topics: Blood Flow Velocity; Blood Volume; Contrast Media; Drug Screening Assays, Antitumor; Gadolinium; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Neoplasms; Neovascularization, Pathologic | 2004 |
Gadofosveset (EPIX/Schering).
Topics: Animals; Capillary Permeability; Cardiovascular Diseases; Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Inflammation; Neoplasms; Organometallic Compounds | 2004 |
Paramagnetic thermosensitive liposomes for MR-thermometry.
Topics: Contrast Media; Gadolinium; Humans; Hyperthermia, Induced; Liposomes; Magnetic Resonance Imaging; Neoplasms; Radiography; Temperature; Thermography | 2005 |
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery.
Topics: Animals; Drug Carriers; Ferrosoferric Oxide; Gadolinium; Gold; Humans; Nanostructures; Neoplasms; Polymers; Quantum Dots; Silicon Dioxide | 2006 |
Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
Topics: Cardiovascular Diseases; Contrast Media; Gadolinium; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Neoplasms | 2007 |
[Magnetic resonance imaging of angiogenesis in tumors].
Topics: Chelating Agents; Contrast Media; Diffusion Magnetic Resonance Imaging; Drug Combinations; Gadolinium; Humans; Magnetic Resonance Angiography; Neoplasms; Neovascularization, Pathologic; Oxygen; Regional Blood Flow; Sensitivity and Specificity | 2007 |
Multimodal MRI contrast agents.
Topics: Contrast Media; Gadolinium; Iron; Lanthanoid Series Elements; Ligands; Magnetic Resonance Imaging; Molecular Structure; Nanoparticles; Neoplasms; Porphyrins | 2007 |
Carbon nanostructures as a new high-performance platform for MR molecular imaging.
Topics: Carbon; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Chemical; Nanoparticles; Nanostructures; Nanotechnology; Nanotubes; Nanotubes, Carbon; Neoplasms | 2007 |
Target molecular therapies: methods to enhance and monitor tumor drug delivery.
Topics: Animals; Catheter Ablation; Contrast Media; Drug Delivery Systems; Gadolinium; Humans; Hyperthermia, Induced; Liposomes; Magnetic Resonance Imaging, Interventional; Neoplasms | 2009 |
Indication-related dosing for magnetic resonance contrast media.
Topics: Contrast Media; Cost-Benefit Analysis; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 1997 |
Gd-DTPA enhances uses for MR imaging of body.
Topics: Cardiomyopathies; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Musculoskeletal Diseases; Neoplasms; Pentetic Acid | 1990 |
[Radioimmunoscintigraphy: fundamentals (1)].
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Iodine Radioisotopes; Neoplasms; Organometallic Compounds; Pentetic Acid; Radioimmunodetection | 1992 |
[Magnetic resonance in oncology].
Topics: Abdominal Neoplasms; Brain Neoplasms; Gadolinium; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasm Metastasis; Neoplasms; Pelvic Neoplasms; Spinal Neoplasms; Thoracic Neoplasms | 1990 |
3 trial(s) available for gadolinium and Benign Neoplasms
| Article | Year |
|---|---|
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Topics: Algorithms; Brain; Brain Neoplasms; Contrast Media; Deep Learning; Diffusion Magnetic Resonance Imaging; Disease Progression; Feasibility Studies; Gadolinium; Germany; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasms; Neural Networks, Computer; Prognosis; Radiology; Retrospective Studies; Tumor Burden | 2021 |
Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.
Topics: Adult; Aged; Benzopyrans; Blood Vessels; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic | 2020 |
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.
Topics: Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Kidney Diseases; Male; Metalloporphyrins; Middle Aged; Neoplasms; Palliative Care; Radiation-Sensitizing Agents | 2000 |
222 other study(ies) available for gadolinium and Benign Neoplasms
| Article | Year |
|---|---|
Aminopeptidase N-targeting nanomolecule-assisted delivery of VEGF siRNA to potentiate antitumour therapy by suppressing tumour revascularization and enhancing radiation response.
Topics: Animals; Antineoplastic Agents; CD13 Antigens; Cell Line, Tumor; Cell Survival; Drug Carriers; Gadolinium; Gold; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred ICR; Nanostructures; Neoplasms; Peptides; Reactive Oxygen Species; RNA, Small Interfering; Vascular Endothelial Growth Factor A; X-Rays | 2021 |
A natural anthocyanin-based multifunctional theranostic agent for dual-modal imaging and photothermal anti-tumor therapy.
Topics: Animals; Anthocyanins; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Female; Gadolinium; Hyperthermia, Induced; Lasers; Magnetic Resonance Imaging; Mice; Mice, Nude; Nanoparticles; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Theranostic Nanomedicine | 2021 |
The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C
Topics: Antineoplastic Agents; Fullerenes; Gadolinium; Humans; Neoplasms; Organometallic Compounds; Voltage-Dependent Anion Channel 1 | 2022 |
Enhanced Tumor Imaging Using Glucosamine-Conjugated Polyacrylic Acid-Coated Ultrasmall Gadolinium Oxide Nanoparticles in Magnetic Resonance Imaging.
Topics: Acrylic Resins; Animals; Contrast Media; Gadolinium; Glucosamine; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms | 2022 |
Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.
Topics: Adult; Aged; Contrast Media; Gadolinium; Humans; Immune Checkpoint Inhibitors; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Myocarditis; Neoplasms; Predictive Value of Tests; Prognosis; Retrospective Studies | 2022 |
Magnetic vortex nanoring coated with gadolinium oxide for highly enhanced T
Topics: Contrast Media; Gadolinium; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Neoplasms; Theranostic Nanomedicine | 2022 |
Metallo-Dye-Based Supramolecular Nanoassembly for NIR-II Cancer Theranostics.
Topics: Cell Line, Tumor; Fluorescent Dyes; Gadolinium; Humans; Hyperthermia, Induced; Neoplasms; Phototherapy; Precision Medicine; Theranostic Nanomedicine | 2022 |
Gadolinium-based ultra-small nanoparticles augment radiotherapy-induced T-cell response to synergize with checkpoint blockade immunotherapy.
Topics: CD8-Positive T-Lymphocytes; Combined Modality Therapy; Gadolinium; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Nanoparticles; Neoplasms; Tumor Microenvironment | 2022 |
In vivo evaluation of the effects of combined boron and gadolinium neutron capture therapy in mouse models.
Topics: Animals; Boron; Boron Compounds; Disease Models, Animal; Gadolinium; Liposomes; Mice; Neoplasms; Neutron Capture Therapy | 2022 |
Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs.
Topics: Chelating Agents; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2022 |
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Topics: Amino Acids; Animals; Contrast Media; Fibrin; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Molecular Imaging; Neoplasms; Oncogene Proteins; Organometallic Compounds; Peptides; Tumor Microenvironment | 2022 |
Low Intensity Focused Ultrasound Ignited "Deep-Penetration Nanobomb" (DPNB) for Tetramodal Imaging Guided Hypoxia-Tolerant Sonodynamic Therapy Against Hypoxic Tumors.
Topics: Cell Line, Tumor; Gadolinium; Humans; Hypoxia; Liposomes; Neoplasms; Oxygen; Tumor Microenvironment; Ultrasonic Therapy | 2022 |
MRI findings of iatrogenic extravasation of gadolinium-based contrast agents in patients with cancer.
Topics: Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Iatrogenic Disease; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Retrospective Studies | 2023 |
AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway.
Topics: Gadolinium; Humans; Nanoparticles; Neoplasms; NF-E2-Related Factor 2; Radiation-Sensitizing Agents; Radiation, Ionizing; Signal Transduction | 2022 |
Gadolinium-Bisphosphonate Nanoparticle-Based Low-Dose Radioimmunotherapy for Osteosarcoma.
Topics: Adolescent; Diphosphonates; Gadolinium; Humans; Nanoparticles; Neoplasms; Ovalbumin; Tumor Microenvironment | 2022 |
Inhibition of DNA synthesis and cancer therapies.
Topics: DNA Replication; Gadolinium; Humans; Iodine; Neoplasms; Nucleotides | 2022 |
Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles.
Topics: Animals; Breast Neoplasms; Gadolinium; Gold; Metal Nanoparticles; Mice; Neoplasms; Radiation-Sensitizing Agents; Serum Albumin, Bovine | 2023 |
Intracellular Construction of Cathepsin B-Guided Gadolinium Nanoparticles for Enhanced T
Topics: Animals; Cathepsin B; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms | 2023 |
Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Neoplasms | 2023 |
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer.
Topics: Apoferritins; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nanoparticles; Neoplasms | 2023 |
Immunological gadolinium-doped mesoporous carbon nanoparticles for tumor-targeted MRI and photothermal-immune co-therapy.
Topics: Carbon; Gadolinium; Humans; Imiquimod; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy | 2023 |
Contrast-enhanced MRI synthesis using dense-dilated residual convolutions based 3D network toward elimination of gadolinium in neuro-oncology.
Topics: Brain; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neoplasms | 2023 |
Simulation of the occipital transtentorial approach incorporating visualization of the cerebellar tentorium using three-dimensional computed tomography angiography and gadolinium-enhanced T1-weighted magnetic resonance imaging: technical note.
Topics: Computed Tomography Angiography; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasms | 2023 |
Significant cell uptake of Gd(III)-diphenylphosphoryl-diphenylphosphonium complexes: evidence for a new conformationally-dependent tumour cell targeting vector.
Topics: Gadolinium; Humans; Neoplasms | 2023 |
Myoglobin-loaded gadolinium nanotexaphyrins for oxygen synergy and imaging-guided radiosensitization therapy.
Topics: Gadolinium; Humans; Magnetic Resonance Imaging; Myoglobin; Neoplasms; Oxygen; Radiation-Sensitizing Agents | 2023 |
Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
Topics: Animals; Boron; Boron Neutron Capture Therapy; Gadolinium; Magnetic Resonance Imaging; Maleimides; Mice; Neoplasms; Neutron Capture Therapy; Tissue Distribution | 2023 |
Reliability of signal intensity in the basal ganglia on non-contrast T1-weighted MR scans after repetitive application of a gadolinium-based contrast agent in pediatric neuro-oncology patients.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Globus Pallidus; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Neoplasms; Organometallic Compounds; Reproducibility of Results; Retrospective Studies | 2023 |
Microfluidic Synthesis of Gd-Based Nanoparticles for Fast and Ultralong MRI Signals in the Solid Tumor.
Topics: A549 Cells; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chelating Agents; Contrast Media; Female; Gadolinium; Human Umbilical Vein Endothelial Cells; Humans; Lab-On-A-Chip Devices; Lipids; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Microfluidics; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Distribution | 2019 |
Nanoassembly and Multiscale Computation of Multifunctional Optical-Magnetic Nanoprobes for Tumor-Targeted Theranostics.
Topics: Animals; Cell Line, Tumor; Folic Acid; Gadolinium; Gold; Humans; Infrared Rays; Magnetic Resonance Imaging; Magnetics; Mice; Mice, Nude; Nanotubes; Neoplasms; Photosensitizing Agents; Phototherapy; Polyethylene Glycols; Porosity; Reactive Oxygen Species; Silicon Dioxide; Theranostic Nanomedicine | 2019 |
Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
Topics: Animals; Cell Line, Tumor; Contrast Media; Ferrocyanides; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Theranostic Nanomedicine; Transplantation, Heterologous | 2019 |
Topics: Animals; Cell Line, Tumor; Contrast Media; Cyclodextrins; Doxorubicin; Drug Delivery Systems; Folic Acid; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Polyesters; Precision Medicine; Theranostic Nanomedicine | 2020 |
Investigating neutron activated contrast agent imaging for tumor localization in proton therapy: a feasibility study for proton neutron gamma-x detection (PNGXD).
Topics: Cadmium Compounds; Contrast Media; Feasibility Studies; Gadolinium; Gamma Rays; Humans; Monte Carlo Method; Neoplasms; Neutrons; Phantoms, Imaging; Proton Therapy; Quantum Dots; Tellurium | 2020 |
Multifunctional gap-enhanced Raman tags for preoperative and intraoperative cancer imaging.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Gadolinium; Humans; Intraoperative Care; Male; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Neoplasms; Preoperative Care; Spectrum Analysis, Raman | 2020 |
An 808 nm Light-Sensitized Upconversion Nanoplatform for Multimodal Imaging and Efficient Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chlorophyllides; Female; Fluorides; Gadolinium; Graphite; Humans; Infrared Rays; Manganese Compounds; Mice; Nanocomposites; Nanoparticles; Neoplasms; Oxides; Oxygen; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Porphyrins; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
Tumor-Specific Endogenous Fe
Topics: Animals; Antineoplastic Agents; Artesunate; Cell Line, Tumor; Cell Survival; Drug Carriers; Ferrous Compounds; Gadolinium; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Methotrexate; Mice; Mice, Nude; Nanoparticles; Neoplasms; Rats; Reactive Oxygen Species; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2020 |
Accurate and Real-Time Temperature Monitoring during MR Imaging Guided PTT.
Topics: Animals; Bismuth; Gadolinium; Magnetic Resonance Imaging; Mice; Nanostructures; Neoplasms; Photothermal Therapy; Sodium Fluoride; Temperature; Thermography | 2020 |
A New Class of Smart Gadolinium Contrast Agent for Tissue pH Probing Using Magnetic Resonance Imaging.
Topics: Animals; Chemistry Techniques, Synthetic; Contrast Media; Disease Models, Animal; Gadolinium; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Models, Chemical; Molecular Structure; Neoplasms; Organ Specificity; Tissue Distribution | 2020 |
Monte Carlo evaluation of the dose sparing and dose enhancement by combination of Gd-infused tumor and
Topics: Americium; Brachytherapy; Gadolinium; Humans; Monte Carlo Method; Neoplasms; Phantoms, Imaging; Radiotherapy Dosage | 2020 |
Selective Decoating-Induced Activation of Supramolecularly Coated Toxic Nanoparticles for Multiple Applications.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bridged-Ring Compounds; Cell Line, Tumor; Escherichia coli; Female; Fluorides; Gadolinium; Hyaluronic Acid; Imidazoles; Infrared Rays; Mice, Inbred C57BL; Microbial Sensitivity Tests; Nanoparticles; Neoplasms; Paraquat; Polyesters; Staphylococcal Infections; Staphylococcus aureus; Thulium; Ytterbium; Zebrafish | 2020 |
An MRI-visible immunoadjuvant based on hollow Gd
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Membrane Permeability; Contrast Media; Drug Discovery; Gadolinium; Humans; Immunotherapy; Interleukin-1beta; Lymph Nodes; Magnetic Resonance Imaging; Mice; Nanospheres; Neoplasms; Ovalbumin; T-Lymphocytes | 2020 |
Nanocomposites of ionic copolymer integrating Gd-containing polyoxometalate as a multiple platform for enhanced MRI and pH-response chemotherapy.
Topics: Animals; Anions; Antineoplastic Agents; Biocompatible Materials; Cell Membrane Permeability; Contrast Media; Doxorubicin; Drug Compounding; Drug Liberation; Gadolinium; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Imaging; Methacrylates; Mice; Nanocapsules; Nanocomposites; Neoplasms; Neoplasms, Experimental; Polyelectrolytes; Polyethylene Glycols; Polymethacrylic Acids; Treatment Outcome; Tumor Microenvironment | 2020 |
Oxygen Vacancy Defect-Induced Activity Enhancement of Gd Doping Magnetic Nanocluster for Oxygen Supplying Cancer Theranostics.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasms; Oxygen; Platinum; Prodrugs; Reactive Oxygen Species; Surface Properties; Theranostic Nanomedicine | 2020 |
A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.
Topics: Animals; Contrast Media; Gadolinium; Humans; Iron; Magnetic Resonance Imaging; Mice; Neoplasms; Renal Insufficiency | 2020 |
Multifunctional Transferrin Encapsulated GdF
Topics: Animals; Fluorescent Dyes; Fluorides; Gadolinium; Humans; Mice; Nanoparticles; Neoplasms; Positron-Emission Tomography; Sentinel Lymph Node; Spectroscopy, Near-Infrared; Tomography, X-Ray Computed; Transferrin | 2020 |
Myocardial damage assessed by late gadolinium enhancement on cardiovascular magnetic resonance imaging in cancer patients treated with anthracyclines and/or trastuzumab.
Topics: Anthracyclines; Cardiomyopathies; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Neoplasms; Predictive Value of Tests; Trastuzumab | 2021 |
Preparation of glycan-oriented imprinted polymer coating Gd-doped silicon nanoparticles for targeting cancer Tn antigens and dual-modal cell imaging via boronate-affinity surface imprinting.
Topics: Gadolinium; Humans; Molecular Imprinting; Nanoparticles; Neoplasms; Polymers; Polysaccharides; Silicon | 2021 |
Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Coordination Complexes; Disease Models, Animal; Female; Gadolinium; Hemin; Humans; Immunogenic Cell Death; Mice; Nanoparticles; Neoplasms; Oxidative Stress; Polymers; Radioimmunotherapy | 2021 |
Doxorubicin (DOX) Gadolinium-Gold-Complex: A New Way to Tune Hybrid Nanorods as Theranostic Agent.
Topics: Animals; Antibiotics, Antineoplastic; Cell Death; Cell Line, Tumor; Doxorubicin; Drug Liberation; Endocytosis; Gadolinium; Gold; Humans; Inhibitory Concentration 50; Magnetic Resonance Imaging; Mice; Nanotubes; Neoplasms; Photothermal Therapy; Spectrophotometry, Ultraviolet; Theranostic Nanomedicine | 2021 |
Investigating plasma volume expanders as novel macromolecular MRI-CEST contrast agents for tumor contrast-enhanced imaging.
Topics: Animals; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Mice; Neoplasms; Plasma Substitutes | 2021 |
Cytosolic delivery of gadolinium via photoporation enables improved in vivo magnetic resonance imaging of cancer cells.
Topics: Cell Tracking; Contrast Media; Cytosol; Gadolinium; Magnetic Resonance Imaging; Neoplasms | 2021 |
Gadolinium-doped hollow silica nanospheres loaded with curcumin for magnetic resonance imaging-guided synergistic cancer sonodynamic-chemotherapy.
Topics: Curcumin; Gadolinium; Magnetic Resonance Imaging; Nanoparticles; Nanospheres; Neoplasms; Silicon Dioxide; Theranostic Nanomedicine | 2021 |
In vivo evaluation of PEGylated-liposome encapsulating gadolinium complexes for gadolinium neutron capture therapy.
Topics: Animals; Cell Line, Tumor; Female; Gadolinium; Humans; Isotopes; Liposomes; Mice, Inbred BALB C; Neoplasms; Neutron Capture Therapy; Polyethylene Glycols | 2021 |
Amphiphilic branched polymer-nitroxides conjugate as a nanoscale agent for potential magnetic resonance imaging of multiple objects in vivo.
Topics: Animals; Cell Survival; Contrast Media; Cyclic N-Oxides; Female; Gadolinium; Heart; Kidney; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Nitrogen Oxides; Polymers | 2021 |
Radiopharmaceutical and Eu
Topics: Animals; Female; Fluorodeoxyglucose F18; Gadolinium; Luminescence; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Nanoparticles; Neoplasms; Optical Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted | 2021 |
Oxygen-Independent Photocleavage of Radical Nanogenerator for Near-IR-Gated and H
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Free Radicals; Gadolinium; Heterocyclic Compounds, 4 or More Rings; Humans; Infrared Rays; Magnetic Resonance Imaging; Mice; Nanomedicine; Nanoparticles; Neoplasms; Neoplasms, Experimental; Oxygen; Photochemotherapy; Reactive Oxygen Species; Silicon Dioxide | 2021 |
Development of MRI-Detectable Boron-Containing Gold Nanoparticle-Encapsulated Biodegradable Polymeric Matrix for Boron Neutron Capture Therapy (BNCT).
Topics: Animals; Boron; Boron Neutron Capture Therapy; Cell Line, Tumor; Gadolinium; Gold; Humans; Metal Nanoparticles; Mice; Neoplasms; Theranostic Nanomedicine | 2021 |
AuGd integrated nanoprobes for optical/MRI/CT triple-modal in vivo tumor imaging.
Topics: Animals; Contrast Media; Female; Gadolinium; Gold; Humans; KB Cells; Magnetic Resonance Imaging; Metal Nanoparticles; Mice, Inbred BALB C; Neoplasms; Tomography, X-Ray Computed | 2017 |
Spherical Polyelectrolyte Brushes as a Novel Platform for Paramagnetic Relaxation Enhancement and Passive Tumor Targeting.
Topics: Animals; Cell Line, Tumor; Dynamic Light Scattering; Gadolinium; Humans; Hydrodynamics; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Optical Imaging; Polyelectrolytes; Static Electricity | 2017 |
Multifunctional Gadolinium-Doped Mesoporous TiO
Topics: Catalysis; Cell Line, Tumor; Cell Survival; Density Functional Theory; Gadolinium; Humans; Hydroxyl Radical; Luminescence; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Optical Imaging; Porosity; Reactive Oxygen Species; Spin Labels; Temperature; Titanium; Ultraviolet Rays; X-Ray Diffraction | 2017 |
Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Capillary Permeability; Contrast Media; Doxorubicin; Drug Liberation; Female; Gadolinium; Magnetic Resonance Imaging; Mice, Nude; Microbubbles; Neoplasms; Polyethylene Glycols; Ultrasonic Therapy | 2017 |
Influence of concentration, nanoparticle size, beam energy, and material on dose enhancement in radiation therapy.
Topics: Computer Simulation; Dose-Response Relationship, Radiation; Gadolinium; Gold; Metal Nanoparticles; Monte Carlo Method; Neoplasms; Particle Size; Phantoms, Imaging; Radiotherapy Dosage | 2017 |
Design of Tumor Acidity-Responsive Sheddable Nanoparticles for Fluorescence/Magnetic Resonance Imaging-Guided Photodynamic Therapy.
Topics: Acids; Antineoplastic Agents; Cell Line, Tumor; Chlorophyllides; Gadolinium; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Optical Imaging; Photochemotherapy; Porphyrins | 2017 |
Efficacy of radiosensitizing doped titania nanoparticles under hypoxia and preparation of an embolic microparticle.
Topics: Cell Line, Tumor; Cobalt; Deferoxamine; Embolization, Therapeutic; Gadolinium; Humans; Nanoparticles; Neoplasms; Radiation-Sensitizing Agents; Titanium; Tumor Hypoxia | 2017 |
Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Coordination Complexes; Gadolinium; Humans; Kinetics; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Particle Size; Surface Properties; Tissue Distribution; Transferrin | 2017 |
Alkaline Phosphatase-Instructed Self-Assembly of Gadolinium Nanofibers for Enhanced T
Topics: Alkaline Phosphatase; Animals; Contrast Media; Gadolinium; HeLa Cells; Heterocyclic Compounds; Humans; Hydrogels; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanofibers; Neoplasms; Oligopeptides; Organometallic Compounds; Phantoms, Imaging | 2017 |
Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
Topics: Animals; Cell Line, Tumor; Chitosan; Gadolinium; Glutathione; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Inbred BALB C; Mice, Nude; Nanospheres; Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Tumor Hypoxia; Tungsten Compounds | 2017 |
Structure-Dependent Antimicrobial Theranostic Functions of Self-Assembled Short Peptide Nanoagents.
Topics: Anti-Infective Agents; Contrast Media; Drug Delivery Systems; Gadolinium; Humans; Magnetic Resonance Imaging; Micelles; Neoplasms; Peptides; Theranostic Nanomedicine | 2017 |
Synthesis of permeable yolk-shell structured gadolinium-doped quantum dots as a potential nanoscale multimodal-visible delivery system.
Topics: Animals; Antibiotics, Antineoplastic; Cadmium Compounds; Delayed-Action Preparations; Doxorubicin; Gadolinium; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Nanocomposites; Neoplasms; Optical Imaging; Permeability; Quantum Dots; Tellurium; Theranostic Nanomedicine; Yolk Sac | 2017 |
In vivo multimodal tumor imaging and photodynamic therapy with novel theranostic agents based on the porphyrazine framework-chelated gadolinium (III) cation.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Fluorescence; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Multimodal Imaging; Neoplasms; Photochemotherapy | 2017 |
Sequential growth of CaF
Topics: Animals; Contrast Media; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Ytterbium | 2017 |
BSA-Bioinspired Gadolinium Hybrid-Functionalized Hollow Gold Nanoshells for NIRF/PA/CT/MR Quadmodal Diagnostic Imaging-Guided Photothermal/Photodynamic Cancer Therapy.
Topics: Gadolinium; Gold; Humans; Nanoshells; Neoplasms; Phototherapy; Serum Albumin, Bovine; Tomography, X-Ray Computed | 2017 |
The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.
Topics: Animals; Chelating Agents; Computer Simulation; Contrast Media; Diffusion; Female; Finite Element Analysis; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Methods; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Reproducibility of Results | 2018 |
Towards an MMP-2-activated molecular agent for cancer imaging.
Topics: Amino Acid Sequence; Enzyme Activation; Gadolinium; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Matrix Metalloproteinase 2; Neoplasms; Organometallic Compounds; Peptides | 2018 |
Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.
Topics: Animals; Biomimetic Materials; Drug Carriers; Endothelium, Vascular; Fluorescent Dyes; Gadolinium; Leukocytes; Membrane Proteins; Mice; Nanoparticles; Neoplasms; Phospholipids; Protein Binding; Rhodamines; Staining and Labeling; Theranostic Nanomedicine; Vascular Diseases | 2018 |
Porphyrin-containing Gadolinium Complex as a Tumor-targeting Magnetic Resonance Imaging (MRI) Contrast Agent.
Topics: Animals; Cell Survival; Contrast Media; Gadolinium; Gadolinium DTPA; HeLa Cells; Humans; Magnetic Resonance Imaging; Neoplasms; Porphyrins; Rabbits | 2018 |
Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Drug Delivery Systems; Drug Liberation; Fever; Gadolinium; High-Intensity Focused Ultrasound Ablation; Humans; Hyperthermia, Induced; Indicators and Reagents; Lipids; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Neoplasms; Optical Imaging; Temperature; Tissue Distribution; Topotecan; Tumor Microenvironment | 2018 |
Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.
Topics: Animals; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Nude; Nanostructures; Neoplasms | 2018 |
Tumor-triggered transformation of chimeric peptide for dual-stage-amplified magnetic resonance imaging and precise photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gadolinium; Humans; Hydrolysis; Magnetic Resonance Imaging; Matrix Metalloproteinase 2; Mice, Nude; Nanoparticles; Neoplasms; Peptides; Photochemotherapy | 2018 |
Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons.
Topics: Boron; Boron Neutron Capture Therapy; Computer Simulation; Dose-Response Relationship, Radiation; Feasibility Studies; Gadolinium; Heavy Ion Radiotherapy; Humans; Isotopes; Models, Biological; Monte Carlo Method; Neoplasms; Neutrons; Phantoms, Imaging; Protons; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2018 |
Stearic Acid-Grafted Chitooligosaccharide Nanomicelle System with Biocleavable Gadolinium Chelates as a Multifunctional Agent for Tumor Imaging and Drug Delivery.
Topics: Animals; Chelating Agents; Chitin; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Mice, Inbred ICR; Micelles; Nanoparticles; Neoplasms; Oligosaccharides; Stearic Acids | 2018 |
Engineered Paramagnetic Graphene Quantum Dots with Enhanced Relaxivity for Tumor Imaging.
Topics: Chelating Agents; Contrast Media; Gadolinium; Graphite; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nanostructures; Neoplasms; Organometallic Compounds; Quantum Dots; Water | 2019 |
Enhancement of mitochondrial ROS accumulation and radiotherapeutic efficacy using a Gd-doped titania nanosensitizer.
Topics: Animals; Apoptosis; Cell Movement; Cell Survival; Drug Carriers; Gadolinium; Humans; MCF-7 Cells; Mice; Mitochondria; Nanocomposites; Neoplasm Transplantation; Neoplasms; Radiation-Sensitizing Agents; Reactive Oxygen Species; Titanium; Transplantation, Heterologous; Treatment Outcome; X-Rays | 2019 |
Evaluation of the sensitivity of R
Topics: Basal Ganglia; Brain; Brain Ischemia; Brain Mapping; Contrast Media; Gadolinium; Gray Matter; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Macromolecular Substances; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasms; Phantoms, Imaging; Reproducibility of Results; Sensitivity and Specificity; Stroke; Tumor Microenvironment; Young Adult | 2019 |
Multifunctional Thermosensitive Liposomes Based on Natural Phase-Change Material: Near-Infrared Light-Triggered Drug Release and Multimodal Imaging-Guided Cancer Combination Therapy.
Topics: Animals; Cell Survival; Doxorubicin; Female; Folic Acid; Gadolinium; HeLa Cells; Humans; Indocyanine Green; Infrared Rays; Liposomes; Magnetic Resonance Imaging; Mice; Mice, Nude; Nanostructures; Neoplasms; Photochemotherapy; Phototherapy; Reactive Oxygen Species; Transplantation, Heterologous | 2019 |
Gadolinium Metallofullerene-Based Activatable Contrast Agent for Tumor Signal Amplification and Monitoring of Drug Release.
Topics: Animals; Contrast Media; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fullerenes; Gadolinium; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Polymers; Tumor Microenvironment | 2019 |
A gadolinium-complex-based theranostic prodrug for in vivo tumour-targeted magnetic resonance imaging and therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Drug Carriers; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Organometallic Compounds; Prodrugs; Signal-To-Noise Ratio; Theranostic Nanomedicine; Transplantation, Heterologous | 2019 |
Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy.
Topics: Cell Line, Tumor; Cell Survival; Contrast Media; Gadolinium; Humans; Indoles; Infrared Rays; Magnetic Resonance Imaging; Microscopy, Confocal; Nanoparticles; Neoplasms; Photoacoustic Techniques; Phototherapy; Polymers; Tobacco Mosaic Virus | 2019 |
Tumor Environment-Responsive Degradable Branched Glycopolymer Magnetic Resonance Imaging Contrast Agent and Its Tumor-Targeted Imaging.
Topics: Contrast Media; Gadolinium; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Neoplasms | 2019 |
Nanoamplifiers synthesized from gadolinium and gold nanocomposites for magnetic resonance imaging.
Topics: Adsorption; Animals; Biological Availability; Cell Survival; Cells, Cultured; Contrast Media; Gadolinium; Gold; Half-Life; Humans; Immunity; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Tissue Distribution | 2013 |
In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Knee Joint; Nanoparticles; Neoplasms; Proteoglycans; Pyridinium Compounds; Quantum Dots; Quaternary Ammonium Compounds; Radionuclide Imaging; Rats | 2013 |
Combination delivery of antigens and CpG by lanthanides-based core-shell nanoparticles for enhanced immune response and dual-mode imaging.
Topics: Animals; Antibodies; Antigens; Cell Line, Tumor; Coordination Complexes; CpG Islands; Cytokines; Enzyme-Linked Immunosorbent Assay; Gadolinium; Lanthanoid Series Elements; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Neoplasms; Oligodeoxyribonucleotides; Ovalbumin; Radiography | 2013 |
Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging.
Topics: Antineoplastic Agents; Cell Survival; Chemoradiotherapy; Cisplatin; Coloring Agents; Contrast Media; Drug Delivery Systems; Gadolinium; HeLa Cells; Humans; Light; Luminescence; Magnetic Resonance Imaging; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Neoplasms; Particle Size; Porosity; Scattering, Radiation; Tetrazolium Salts; Thiazoles | 2013 |
Conjugation of NaGdF4 upconverting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging.
Topics: Animals; Cell Death; Cell Line, Tumor; Contrast Media; Diagnostic Imaging; Fluorides; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanospheres; Neoplasms; Poloxamer; Silicon Dioxide; Spectrum Analysis; Tomography, X-Ray Computed | 2013 |
Tumor targeting and MR imaging with lipophilic cyanine-mediated near-infrared responsive porous Gd silicate nanoparticles.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Endocytosis; Fibroblasts; Fluorescence; Gadolinium; Heterocyclic Compounds; Humans; Indocyanine Green; Lipids; Magnetic Resonance Imaging; Mice; Mice, SCID; Nanoparticles; Neoplasms; Organ Specificity; Organometallic Compounds; Porosity; Propylamines; Silanes; Silicates; Spectroscopy, Near-Infrared; Time Factors | 2013 |
The biodistribution of gold nanoparticles designed for renal clearance.
Topics: Animals; Contrast Media; Gadolinium; Gold; Kidney; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Neoplasms; Radionuclide Imaging; Rats; Rats, Inbred F344; Tomography, X-Ray Computed | 2013 |
Tumor growth suppression by gadolinium-neutron capture therapy using gadolinium-entrapped liposome as gadolinium delivery agent.
Topics: Animals; Antineoplastic Agents; Boron; Drug Delivery Systems; Gadolinium; Japan; Liposomes; Male; Mice; Mice, Inbred BALB C; Neoplasms; Neutron Capture Therapy | 2013 |
Gadolinium-deferasirox-D-glucosamine: novel anti-tumor and MR molecular (theranostic) imaging agent.
Topics: Animals; Antineoplastic Agents; Benzoates; Cell Line, Tumor; Chromatography, Thin Layer; Contrast Media; Deferasirox; Disease Models, Animal; Gadolinium; Glucosamine; Glucose; Hexokinase; Humans; Magnetic Resonance Imaging; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Phosphorylation; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Triazoles; Tumor Necrosis Factor-alpha | 2013 |
Gadolinium-coordinated elastic nanogels for in vivo tumor targeting and imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Diagnostic Imaging; Gadolinium; Male; Mice; Mice, Nude; Nanogels; Neoplasms; Polyethylene Glycols; Polyethyleneimine | 2013 |
Gadolinium-chelate functionalized copper sulphide as a nanotheranostic agent for MR imaging and photothermal destruction of cancer cells.
Topics: Chelating Agents; Copper; Gadolinium; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Resonance Imaging; Models, Molecular; Nanoparticles; Neoplasms; Phototherapy; Sulfides | 2013 |
Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gadolinium; Magnetic Resonance Imaging; Melanoma, Experimental; Mice; Nanoparticles; Neoplasms; Radiography; Skin Neoplasms | 2013 |
Folate grafted Prussian Blue entrapped with gadolinium(III) as a new contrast agent for tumor-targeted magnetic resonant imaging.
Topics: Animals; Cell Line; Colloids; Contrast Media; Dose-Response Relationship, Drug; Female; Ferrocyanides; Folic Acid; Gadolinium; Ions; Kidney; Ligands; Magnetic Resonance Imaging; Magnetics; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Neoplasms | 2013 |
Gd-labeled glycol chitosan as a pH-responsive magnetic resonance imaging agent for detecting acidic tumor microenvironments.
Topics: Acids; Animals; Chitosan; Contrast Media; Gadolinium; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Structure; Neoplasms; NIH 3T3 Cells; Radiography; Reproducibility of Results; Sensitivity and Specificity; Succinimides; Tumor Microenvironment | 2013 |
Gadolinium complex of DO3A-benzothiazole aniline (BTA) conjugate as a theranostic agent.
Topics: Animals; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contrast Media; Female; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms; Organometallic Compounds; Sensitivity and Specificity; Xenograft Model Antitumor Assays | 2013 |
Highly uniform hollow GdF3 spheres: controllable synthesis, tuned luminescence, and drug-release properties.
Topics: Doxorubicin; Drug Delivery Systems; Fluorides; Gadolinium; HeLa Cells; Humans; Iron; Lanthanoid Series Elements; Luminescence; Microscopy, Electron, Transmission; Nanospheres; Neoplasms; X-Ray Diffraction | 2013 |
Gadolinium-conjugated gold nanoshells for multimodal diagnostic imaging and photothermal cancer therapy.
Topics: Animals; Disulfides; Gadolinium; Gold; Hyperthermia, Induced; Luminescence; Melanoma, Experimental; Mice; Multimodal Imaging; Nanoshells; Neoplasms; Phantoms, Imaging; Photons; Phototherapy; Polyethylene Glycols; Spectroscopy, Near-Infrared; Subcutaneous Tissue; Tomography, Optical Coherence | 2014 |
A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Contrast Media; Fluorides; Gadolinium; HeLa Cells; Humans; Infrared Rays; Magnetic Resonance Imaging; Metal Nanoparticles; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Polysorbates; Quinones; Radiography; Singlet Oxygen; Yttrium | 2013 |
An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Topics: Angiography; Animals; Contrast Media; Female; Gadolinium; Half-Life; Heterocyclic Compounds; Humans; Lysine; Magnetic Resonance Imaging; Mice; Mice, SCID; Neoplasms; Organometallic Compounds; Tissue Distribution | 2014 |
Multifunctional core-shell structured nanocarriers for synchronous tumor diagnosis and treatment in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Contrast Media; Doxorubicin; Drug Carriers; Erbium; Fluorides; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetics; Mice; Nanocomposites; Nanoparticles; Neoplasms; Polyethylene Glycols; Porosity; Ytterbium | 2014 |
Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imaging.
Topics: Animals; Cell Line; Coordination Complexes; Diagnostic Imaging; Fluorescent Dyes; Gadolinium; Humans; Lanthanoid Series Elements; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Molecular Structure; Neoplasms; Rhodamines | 2013 |
Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments.
Topics: Animals; Binding Sites; Contrast Media; Coordination Complexes; Crystallography, X-Ray; Gadolinium; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Mice; Mice, Nude; Molecular Docking Simulation; Neoplasms; Neurotensin; Positron-Emission Tomography; Protein Structure, Tertiary; Receptors, Neurotensin; Tissue Distribution; Transplantation, Heterologous | 2013 |
High mitochondrial accumulation of new gadolinium(III) agents within tumour cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Gadolinium; Humans; Mitochondria; Molecular Structure; Neoplasms; Organometallic Compounds; Structure-Activity Relationship | 2014 |
Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Contrast Media; Doxorubicin; Female; Gadolinium; Heterocyclic Compounds; Humans; Liposomes; Mice; Neoplasms; Neuropilin-1; Oligopeptides; Organometallic Compounds; Polyethylene Glycols; Tumor Burden | 2014 |
Folate-targeted gadolinium-lipid-based nanoparticles as a bimodal contrast agent for tumor fluorescent and magnetic resonance imaging.
Topics: Animals; Contrast Media; Female; Folic Acid Transporters; Gadolinium; Humans; KB Cells; Lipids; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Optical Imaging; Tissue Distribution | 2014 |
Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
Topics: Amino Acid Sequence; Binding Sites; Catalytic Domain; Fullerenes; Gadolinium; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Models, Molecular; Molecular Sequence Data; Nanomedicine; Neoplasms; Protein Binding; Protein Conformation; Sequence Alignment; Signal Transduction | 2014 |
Translating bioinorganic chemistry.
Topics: Antineoplastic Agents; Chemistry, Bioinorganic; Cisplatin; Coordination Complexes; Gadolinium; Humans; Magnetic Resonance Imaging; Metals; Neoplasms | 2014 |
Gadolinium-based nanoparticles for highly efficient T1-weighted magnetic resonance imaging.
Topics: Animals; BALB 3T3 Cells; Cell Line, Tumor; Coated Materials, Biocompatible; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Neoplasms; Polyethylene Glycols; Pyrenes | 2014 |
Ultrasonic assisted preparation of lanthanide-oleate complexes for the synthesis of multifunctional monodisperse upconversion nanoparticles for multimodal imaging.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Fluorides; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oleic Acid; Sonication; Tomography, X-Ray Computed; Transplantation, Heterologous; Yttrium | 2014 |
Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Contrast Media; Doxorubicin; Drug Delivery Systems; Female; Fluorides; Folic Acid; Gadolinium; Humans; Luminescent Agents; Magnetic Resonance Imaging; Mice; Models, Molecular; Multimodal Imaging; Nanoparticles; Neoplasms; Tomography, X-Ray Computed; Yttrium | 2014 |
DNA hydrogel by multicomponent assembly for encapsulation and killing of cells.
Topics: Animals; Biocompatible Materials; Cations; Chelating Agents; Cross-Linking Reagents; DNA; Gadolinium; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Jurkat Cells; Microscopy, Electron, Scanning; Neoplasms; Oxygen; Reactive Oxygen Species; Salmon; Thiophenes | 2014 |
Mechanical downsizing of a gadolinium(III)-based metal-organic framework for anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Benzene Derivatives; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Fluorescent Dyes; Gadolinium; Humans; Mice; Models, Molecular; Neoplasms; Organometallic Compounds; Porosity | 2014 |
An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery.
Topics: Albumins; Animals; Contrast Media; Female; Fluorescence; Gadolinium; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mice; Mice, Nude; Multimodal Imaging; Nanostructures; Neoplasms; Protein Conformation; Treatment Outcome | 2014 |
Platinum(II)-gadolinium(III) complexes as potential single-molecular theranostic agents for cancer treatment.
Topics: Animals; Antineoplastic Agents; Gadolinium; Humans; Mice; Models, Molecular; Neoplasms; Platinum | 2014 |
Monte Carlo study of radiation dose enhancement by gadolinium in megavoltage and high dose rate radiotherapy.
Topics: Brachytherapy; Contrast Media; Gadolinium; Humans; Metalloporphyrins; Monte Carlo Method; Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage | 2014 |
Synthesis and biological evaluation of a class of mitochondrially-targeted gadolinium(III) agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Gadolinium; Humans; Mass Spectrometry; Mitochondria; Neoplasms; Organophosphorus Compounds; Spectrometry, X-Ray Emission | 2014 |
Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells.
Topics: Contrast Media; Fluorides; Gadolinium; HEK293 Cells; HeLa Cells; Humans; Magnetic Resonance Imaging; Microscopy, Confocal; Nanoparticles; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Quinones; Silicon Dioxide; Yttrium | 2014 |
In vivo selective cancer-tracking gadolinium eradicator as new-generation photodynamic therapy agent.
Topics: Animals; Drug Delivery Systems; Gadolinium; Humans; Mice; Neoplasms; Photochemotherapy | 2014 |
Graphene oxide-BaGdF5 nanocomposites for multi-modal imaging and photothermal therapy.
Topics: Animals; Barium; Barium Compounds; Cell Death; Fluorides; Gadolinium; Graphite; HeLa Cells; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Mice; Mice, Nude; Multimodal Imaging; Nanocomposites; Neoplasms; Oxides; Phototherapy; Polyethylene Glycols; Solutions; Spectroscopy, Fourier Transform Infrared; Spectroscopy, Near-Infrared; Tomography, X-Ray Computed; X-Ray Diffraction | 2015 |
Self-assembled polymeric nanoparticles as new, smart contrast agents for cancer early detection using magnetic resonance imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Early Detection of Cancer; Gadolinium; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Imaging; MCF-7 Cells; Mesenchymal Stem Cells; Methacrylates; Mice; Micelles; Nanoparticles; Neoplasms; Polymers | 2015 |
Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers.
Topics: Animals; Cell Death; Cell Survival; Female; Folic Acid; Gadolinium; HeLa Cells; Humans; Luminescence; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Mice, Nude; Nanocomposites; Neoplasms; Photochemotherapy; Photosensitizing Agents; Scattering, Radiation; Silicon Dioxide; Spectroscopy, Near-Infrared; Static Electricity; Titanium; X-Ray Diffraction | 2015 |
Facile preparation and bifunctional imaging of Eu-doped GdPO4 nanorods with MRI and cellular luminescence.
Topics: Animals; Cell Line; Cell Survival; Contrast Media; Europium; Fibroins; Gadolinium; Hep G2 Cells; Humans; Luminescence; Magnetic Resonance Imaging; Mice; Nanotubes; Neoplasms; Peptides; Phosphates | 2015 |
Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Topics: Animals; Body Weight; Camptothecin; Cell Death; Europium; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Imaging; Mice; Multimodal Imaging; Nanoparticles; Neoplasms; Porosity; Silicon Dioxide; X-Ray Diffraction | 2015 |
Quantitative analysis of Gd@C82(OH)22 and cisplatin uptake in single cells by inductively coupled plasma mass spectrometry.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Gadolinium; Humans; Mass Spectrometry; Nanostructures; Neoplasms; Single-Cell Analysis | 2015 |
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study.
Topics: Adolescent; Child; Cohort Studies; Contrast Media; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Neoplasms; Pilot Projects; Reproducibility of Results; Respiration; Sensitivity and Specificity | 2015 |
Gd-loaded-RBCs for the assessment of tumor vascular volume by contrast-enhanced-MRI.
Topics: Animals; Biocompatible Materials; Brain; Contrast Media; Erythrocytes; Female; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Muscles; Neoplasms; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Tumor Burden | 2015 |
Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.
Topics: Animals; Chelating Agents; Coloring Agents; Contrast Media; Female; Gadolinium; Humans; Infrared Rays; Magnetic Resonance Imaging; MCF-7 Cells; Mice, Nude; Multimodal Imaging; Neoplasms; Optical Imaging; Tissue Distribution | 2015 |
Enhanced red upconversion emission, magnetoluminescent behavior, and bioimaging application of NaSc0.75Er0.02Yb0.18Gd0.05F4@AuNPs nanoparticles.
Topics: Cell Line, Tumor; Gadolinium; Gold; HeLa Cells; Humans; Luminescence; Molecular Imaging; Nanoparticles; Neoplasms; Particle Size; Ytterbium; Yttrium | 2015 |
Facile Synthesis of Gd-Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Copper; Dextrans; Disease Models, Animal; Gadolinium; Humans; Indium; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasms; Optical Imaging; Polyethylene Glycols; Quantum Dots; Stearic Acids; Sulfides; Tissue Distribution; Unilamellar Liposomes; Zinc Compounds | 2015 |
Multifunctional Magnetic Gd(3+) -Based Coordination Polymer Nanoparticles: Combination of Magnetic Resonance and Multispectral Optoacoustic Detections for Tumor-Targeted Imaging in vivo.
Topics: Animals; Carbon; Cells, Cultured; Ferrosoferric Oxide; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Microspheres; Multimodal Imaging; Neoplasms; Optical Imaging; Photoacoustic Techniques; Polymers | 2015 |
Gadolinium(III)-Chelated Silica Nanospheres Integrating Chemotherapy and Photothermal Therapy for Cancer Treatment and Magnetic Resonance Imaging.
Topics: Antineoplastic Agents; Cell Death; Chelating Agents; Endocytosis; Gadolinium; Humans; Hyperthermia, Induced; Infrared Rays; Ions; Magnetic Resonance Imaging; MCF-7 Cells; Nanospheres; Neoplasms; Phototherapy; Silicon Dioxide; Spectrophotometry, Ultraviolet; Temperature; X-Ray Absorption Spectroscopy | 2015 |
Bottom-Up Synthesis of Metal-Ion-Doped WS₂ Nanoflakes for Cancer Theranostics.
Topics: Animals; Cell Line, Tumor; Fluorescent Antibody Technique; Gadolinium; Hyperthermia, Induced; Ions; Metals; Mice, Inbred BALB C; Nanostructures; Neoplasms; Phototherapy; Polyethylene Glycols; Sulfides; Theranostic Nanomedicine; Tungsten Compounds | 2015 |
Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Topics: Adolescent; Chelating Agents; Child; Child, Preschool; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Infant; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
A Protein-Corona-Free T(1)-T(2) Dual-Modal Contrast Agent for Accurate Imaging of Lymphatic Tumor Metastasis.
Topics: Animals; Contrast Media; Female; Ferric Compounds; Gadolinium; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mice; Mice, Inbred ICR; Neoplasms; Radiography | 2015 |
Facile synthesis of CdTe@GdS fluorescent-magnetic nanoparticles for tumor-targeted dual-modal imaging.
Topics: Animals; Cadmium Compounds; Cell Survival; Fluorescent Dyes; Gadolinium; Humans; KB Cells; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Neoplasms; Spectroscopy, Fourier Transform Infrared; Sulfides; Tellurium | 2016 |
Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2016 |
Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging.
Topics: Animals; Cell Death; Cell Line, Tumor; Gadolinium; Gold; Humans; Immunohistochemistry; Integrin alphaVbeta3; Magnetic Resonance Imaging; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Radiation Tolerance; Subcellular Fractions; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2016 |
Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Fullerenes; Gadolinium; Humans; Immunotherapy, Adoptive; Macrophages; Mice; Mitochondria; Nanoparticles; Neoplasm Metastasis; Neoplasms | 2016 |
Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
Topics: Animals; Cattle; Gadolinium; HeLa Cells; Humans; Kidney; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Organometallic Compounds | 2016 |
Harnessing the Cancer Radiation Therapy by Lanthanide-Doped Zinc Oxide Based Theranostic Nanoparticles.
Topics: Cell Survival; Europium; Gadolinium; HeLa Cells; Humans; Lanthanoid Series Elements; Magnetic Resonance Imaging; Metal Nanoparticles; Neoplasms; Radiation; Theranostic Nanomedicine; X-Ray Diffraction; Zinc Oxide | 2016 |
Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Female; Gadolinium; Gemcitabine; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Mice, Nude; Nanoparticles; Neoplasms; Solutions | 2016 |
"Comet tail sign": A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Prognosis; Retrospective Studies | 2016 |
Mesoporous silica nanoparticles functionalized with fluorescent and MRI reporters for the visualization of murine tumors overexpressing αvβ3 receptors.
Topics: Animals; Cell Line, Tumor; Female; Fluorescent Dyes; Gadolinium; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Molecular Diagnostic Techniques; Nanoparticles; Neoplasms; Optical Imaging; Porosity; Silicon Dioxide; Up-Regulation | 2016 |
ProCA1.GRPR: a new imaging agent in cancer detection.
Topics: Animals; Biomarkers, Tumor; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Neoplasms; Prostatic Neoplasms; Receptors, Bombesin | 2016 |
Pushing radiation therapy limitations with theranostic nanoparticles.
Topics: Gadolinium; Humans; Nanoparticles; Neoplasms; Theranostic Nanomedicine | 2016 |
Synergistic Effect of Human Serum Albumin and Fullerene on Gd-DO3A for Tumor-Targeting Imaging.
Topics: Animals; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Neoplasms; Organometallic Compounds; Serum Albumin | 2016 |
Improving proton therapy by metal-containing nanoparticles: nanoscale insights.
Topics: DNA; Gadolinium; Humans; Metal Nanoparticles; Molecular Probes; Neoplasms; Plasmids; Platinum; Proton Therapy; Protons | 2016 |
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy.
Topics: Animals; DNA Damage; Female; Gadolinium; Lasers; Macaca fascicularis; Magnetic Resonance Imaging; Male; Mice; Nanoparticles; Neoplasms; Radiation-Sensitizing Agents; Radiotherapy, Image-Guided; Silicon Dioxide; Theranostic Nanomedicine | 2016 |
Graphene Oxide and Gadolinium-Chelate Functionalized Poly(lactic acid) Nanocapsules Encapsulating Perfluorooctylbromide for Ultrasound/Magnetic Resonance Bimodal Imaging Guided Photothermal Ablation of Cancer.
Topics: Biocompatible Materials; Chelating Agents; Fluorocarbons; Gadolinium; Graphite; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrocarbons, Brominated; Hyperthermia, Induced; Lactic Acid; Magnetic Resonance Imaging; Nanocapsules; Neoplasms; Oxides; Phototherapy; Polyesters; Polymers; Ultrasonography | 2016 |
Gd-Hybridized Plasmonic Au-Nanocomposites Enhanced Tumor-Interior Drug Permeability in Multimodal Imaging-Guided Therapy.
Topics: Gadolinium; Gold; Multimodal Imaging; Nanocomposites; Neoplasms; Permeability | 2016 |
Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes.
Topics: Adult; Child; Child, Preschool; Cohort Studies; Contrast Media; Female; Fetal Development; Gadolinium; Gestational Age; Hearing Loss; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Neoplasms; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Retrospective Studies; Risk; Stillbirth; Vision Disorders | 2016 |
Preparation and In Vitro Evaluation of a MRI Contrast Agent Based on Aptamer-Modified Gadolinium-Loaded Liposomes for Tumor Targeting.
Topics: Animals; Aptamers, Nucleotide; Contrast Media; Flow Cytometry; Gadolinium; Humans; Liposomes; Magnetic Resonance Imaging; Microscopy, Confocal; Neoplasms; Particle Size | 2017 |
Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Comorbidity; Contrast Media; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Prevalence; Respiration Disorders; Retrospective Studies; Risk Factors | 2016 |
Gadolinium-Loaded Polychelating Polymer-Containing Tumor-Targeted Liposomes.
Topics: Animals; Antibodies; Cell Line, Tumor; Chelating Agents; Gadolinium; Humans; Liposomes; Magnetic Resonance Imaging; Mice; Microscopy, Fluorescence; Neoplasms; Polyethylene Glycols; Polymers | 2017 |
Gd
Topics: Contrast Media; Erythrocytes; Gadolinium; Humans; Magnetic Resonance Imaging; Nanoparticles; Neoplasms | 2016 |
Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics.
Topics: Aged; Animals; Apoptosis; Biocompatible Materials; Colloids; Contrast Media; Drug Delivery Systems; Female; Gadolinium; Hemolysis; Humans; Liposomes; Magnetic Resonance Imaging; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Nanoparticles; Neoplasms; Peptides; Porosity; Silicon Dioxide; Theranostic Nanomedicine | 2017 |
Direct arterial injection of hyperpolarized
Topics: Animals; Arteries; Carbon Isotopes; Drug Delivery Systems; Epigastric Arteries; Female; Femoral Vein; Gadolinium; Magnetic Resonance Spectroscopy; Male; Neoplasm Metastasis; Neoplasms; Optical Imaging; Perfusion; Phosphorylation; Pyruvic Acid; Rats; Spectrophotometry; Stilbenes | 2017 |
Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Humans; Lipid Peroxidation; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Topics: Amides; Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Angiography; Mice; Mice, Nude; Molecular Conformation; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds | 2008 |
Retrospective analysis of radiation load during examination of cancer patients by (68)Ga-DOTATOC and (18)F-FDG positron emission tomography.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gadolinium; Humans; Neoplasms; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.
Topics: Biological Transport; Carrier Proteins; Cell Line, Tumor; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Gadolinium; Gene Expression Regulation, Neoplastic; Humans; Ligands; Liposomes; Magnetic Resonance Imaging; Magnetics; Microscopy, Fluorescence; Neoplasms; Receptors, Cell Surface | 2009 |
Progress in the use of gadolinium for NCT.
Topics: Gadolinium; Humans; Isotopes; Monte Carlo Method; Neoplasms; Neutron Capture Therapy; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted | 2009 |
Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
Topics: Animals; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Combined Modality Therapy; Dog Diseases; Dogs; Gadolinium; Humans; Melanoma; Mouth Neoplasms; Neoplasms; Neutron Capture Therapy; Osteosarcoma; Phenylalanine | 2009 |
Peptide-targeted diagnostics and radiotherapeutics.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cell Line; ErbB Receptors; Gadolinium; Humans; Lutetium; Male; Molecular Sequence Data; Neoplasms; Oligopeptides; Peptides; Positron-Emission Tomography; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Rats; Receptors, G-Protein-Coupled; Tuftsin | 2009 |
New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.
Topics: Animals; Contrast Media; Gadolinium; Humans; Ligands; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Organometallic Compounds; Rats; Serum Albumin; Vanadates; Vanadium | 2009 |
Imaging of gadolinium spatial distribution in tumor tissue by laser ablation inductively coupled plasma mass spectrometry.
Topics: Animals; Cell Line, Tumor; Diagnostic Imaging; Female; Gadolinium; Humans; Kidney; Laser Therapy; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Neoplasms; Spectrophotometry, Atomic | 2010 |
Geant4 estimation model of high Z atom concentration for tumor vessel ablation.
Topics: Algorithms; Apoptosis; Computer Simulation; Endothelial Cells; Gadolinium; Gold; Humans; Monte Carlo Method; Neoplasms; Photons; Platinum; Radiation Dosage; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Software; Uranium | 2009 |
Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.
Topics: Animals; Contrast Media; Cross-Linking Reagents; Dendrimers; Electron Spin Resonance Spectroscopy; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Gadolinium; Gadolinium DTPA; Humans; KB Cells; Magnetic Resonance Imaging; Mice; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental | 2010 |
Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes.
Topics: Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Contrast Media; Gadolinium; Humans; Liposomes; Magnetic Resonance Imaging; Neoplasms; Polylysine | 2010 |
Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
Topics: Chitosan; Cholic Acids; Fluorescence; Fluorescent Dyes; Gadolinium; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Spectroscopy, Near-Infrared | 2010 |
Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy.
Topics: Animals; Chlorophyll; Fluorescence; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms; Photochemotherapy; Rats | 2010 |
Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813.
Topics: Animals; Benzamides; Cell Line, Tumor; Contrast Media; Gadolinium; Indoles; Macrophages; Magnetic Resonance Imaging; Mice; Neoplasms; Polyglutamic Acid; Rats | 2010 |
Gain of a 500-fold sensitivity on an intravital MR contrast agent based on an endohedral gadolinium-cluster-fullerene-conjugate: a new chance in cancer diagnostics.
Topics: Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2010 |
Gadolinium-labeled quantum dots for molecular magnetic resonance imaging: R1 versus R2 mapping.
Topics: Animals; Contrast Media; Gadolinium; Kidney; Liver; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasms; Quantum Dots; Radiography; Spleen | 2010 |
Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo.
Topics: Animals; Biological Transport; Cell Line, Tumor; ErbB Receptors; Gadolinium; Half-Life; Humans; Kupffer Cells; Liver; Male; Mice; Models, Biological; Molecular Imaging; Molecular Probes; Neoplasms; Quantum Dots; Reproducibility of Results | 2010 |
Neutron capture nuclei-containing carbon nanoparticles for destruction of cancer cells.
Topics: Boron; Boron Neutron Capture Therapy; Carbon; Cell Survival; Cobalt; Gadolinium; HeLa Cells; Humans; Isotopes; Nanoparticles; Neoplasms; Neutron Capture Therapy | 2010 |
Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.
Topics: Animals; Antibiotics, Antineoplastic; Contrast Media; Doxorubicin; Gadolinium; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Rats; Temperature; Ultrasonics; Ultrasonography | 2011 |
Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Topics: Cell Line; Contrast Media; Ferric Compounds; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Materials Testing; Molecular Structure; Neoplasms; Particle Size; X-Ray Diffraction | 2011 |
Amphiphilic multiarm star block copolymer-based multifunctional unimolecular micelles for cancer targeted drug delivery and MR imaging.
Topics: Animals; Cell Death; Cell Survival; Drug Delivery Systems; Folic Acid; Gadolinium; HeLa Cells; Humans; Hydrodynamics; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methacrylates; Micelles; Microscopy, Atomic Force; Neoplasms; Organ Specificity; Paclitaxel; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Surface-Active Agents; Time Factors | 2011 |
Using laser ablation/inductively coupled plasma mass spectrometry to bioimage multiple elements in mouse tumors after hyperthermia.
Topics: Animals; Cell Line, Tumor; Elements; Ferric Compounds; Gadolinium; Hot Temperature; Humans; Laser Therapy; Male; Mass Spectrometry; Metal Nanoparticles; Metals, Heavy; Mice; Mice, Inbred C57BL; Neoplasms; Prostatic Neoplasms; Radiography; Staining and Labeling | 2011 |
Highly biocompatible TiO₂:Gd³⁺ nano-contrast agent with enhanced longitudinal relaxivity for targeted cancer imaging.
Topics: Biocompatible Materials; Cell Line; Cell Membrane; Contrast Media; Cytokines; Gadolinium; Hemolysis; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Neoplasms; Platelet Aggregation; Radionuclide Imaging; Reactive Oxygen Species; Rhodamine 123; Titanium | 2011 |
Macromolecular nanotheranostics for multimodal anticancer therapy.
Topics: Acrylamides; Animals; Antineoplastic Agents; Doxorubicin; Drug Carriers; Gadolinium; Humans; Iodine Radioisotopes; Mice; Nanomedicine; Neoplasms; Tissue Distribution | 2011 |
Nanoparticles could have a bright future in cancer cell labeling.
Topics: Energy Transfer; Gadolinium; Humans; Nanoparticles; Neoplasms; Staining and Labeling | 2012 |
A DTTA-ligated uridine-quantum dot conjugate as a bimodal contrast agent for cellular imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Flow Cytometry; Gadolinium; Magnetic Resonance Imaging; Mice; Microscopy, Fluorescence; Molecular Structure; Neoplasms; Organometallic Compounds; Quantum Dots; Uridine | 2012 |
Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation.
Topics: Animals; Biocompatible Materials; Contrast Media; Gadolinium; Gadolinium DTPA; Gases; High-Intensity Focused Ultrasound Ablation; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Phantoms, Imaging; Phospholipids; Phosphorus; Tetrazolium Salts; Thiazoles; Treatment Outcome | 2012 |
In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles.
Topics: Animals; Apoptosis; Cell Line, Tumor; Gadolinium; Hep G2 Cells; Humans; Metal Nanoparticles; Metals, Rare Earth; Mice; Neoplasms; Reactive Oxygen Species; Titanium; Transplantation, Heterologous; Ultraviolet Rays; X-Rays | 2012 |
Multifunctional receptor-targeted nanocomplexes for magnetic resonance imaging and transfection of tumours.
Topics: Animals; Cell Line, Tumor; Contrast Media; Female; Gadolinium; Gene Transfer Techniques; Genetic Therapy; Kinetics; Ligands; Liposomes; Luciferases; Magnetic Resonance Imaging; Mice; Models, Chemical; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Neoplasms; Neurotensin; Peptides; Tetanus Toxin; Transfection | 2012 |
Hyperbranched conjugated polyelectrolyte for dual-modality fluorescence and magnetic resonance cancer imaging.
Topics: Animals; Body Weight; Cell Line, Tumor; Electrolytes; Fluorescent Dyes; Gadolinium; Humans; Luminescence; Magnetic Resonance Imaging; Male; MCF-7 Cells; Mice; Mice, Inbred ICR; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Neoplasm Transplantation; Neoplasms; Photochemistry; Polymers; Quantum Theory | 2012 |
Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles.
Topics: Cell Line, Tumor; Cell Membrane; Cell Survival; Diffusion; Gadolinium; Humans; Kinetics; Nanoparticles; Neoplasms; Particle Size; Pinocytosis; Pseudopodia; Radiation-Sensitizing Agents; Time Factors; Vacuoles | 2013 |
Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents.
Topics: Animals; Cell Line, Tumor; Contrast Media; Dimerization; Europium; Furin; Gadolinium; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Mice, Nude; Microscopy, Confocal; Neoplasms; Radiography; Transplantation, Heterologous | 2013 |
A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery.
Topics: Animals; Antineoplastic Agents; Contrast Media; Drug Delivery Systems; Gadolinium; Gold; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hydroxides; Intracellular Space; Magnetic Resonance Imaging; Mice; Nanocomposites; Neoplasms; Tomography, X-Ray Computed; X-Ray Diffraction | 2013 |
Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Docetaxel; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Paclitaxel; Radiography; Rats; Rats, Inbred F344; Taxoids; Time Factors; Treatment Outcome | 2002 |
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
Topics: Animals; Coated Materials, Biocompatible; Disease Models, Animal; Endocytosis; Female; Folic Acid; Gadolinium; Humans; KB Cells; Mice; Mice, Nude; Nanotechnology; Neoplasms; Particle Size; Polyethylene Glycols; Technology, Pharmaceutical; Tissue Distribution | 2004 |
A comparison of the COG and MCNP codes in computational neutron capture therapy modeling, Part II: gadolinium neutron capture therapy models and therapeutic effects.
Topics: Body Burden; Computer Simulation; Gadolinium; Humans; Isotopes; Models, Biological; Neoplasms; Neutron Capture Therapy; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Relative Biological Effectiveness; Software; Software Validation; Treatment Outcome | 2005 |
Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice.
Topics: Animals; Antioxidants; Blood Coagulation; Carcinoma, Hepatocellular; Female; Fullerenes; Gadolinium; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Tissue Distribution; Xenograft Model Antitumor Assays | 2006 |
Gadolinium-loaded polychelating polymer-containing cancer cell-specific immunoliposomes.
Topics: Antibodies, Monoclonal; Chelating Agents; Contrast Media; Enzyme-Linked Immunosorbent Assay; Gadolinium; Liposomes; Magnetic Resonance Imaging; Neoplasms; Polymers | 2006 |
Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Cobalt Radioisotopes; Contrast Media; Excipients; Fullerenes; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Neoplasm Transplantation; Neoplasms; Pentetic Acid; Photochemotherapy; Polyethylene Glycols; Superoxides | 2007 |
[Utility of MRI contrast agents for diagnosis and treatment follow-up in cancer].
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Capillary Permeability; Contrast Media; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microcirculation; Neoplasms; Prognosis | 2007 |
A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging.
Topics: Animals; Avidin; Cell Death; Cell Line, Tumor; Gadolinium; Magnetic Resonance Imaging; Mice; Molecular Probes; Neoplasms; Synaptotagmin I | 2007 |
Polymer platforms for drug delivery and biomedical imaging.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Contrast Media; Drug Carriers; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Polymers | 2007 |
Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron capture.
Topics: Boron Neutron Capture Therapy; Brachytherapy; Californium; Cell Survival; Gadolinium; Humans; Isotopes; Neoplasms; Neutron Capture Therapy; Neutrons; Scattering, Radiation | 1994 |
Metal ion speciation in blood plasma: gallium-67-citrate and MRI contrast agents.
Topics: Citrates; Citric Acid; Computer Simulation; Contrast Media; Gadolinium; Gallium; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Neoplasms; Radionuclide Imaging; Tissue Distribution | 1996 |
Design and preparation of gadolinium-reservoir microcapsules for neutron-capture therapy by means of the Wurster process.
Topics: Acrylates; Calcium Carbonate; Capsules; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Gadolinium; Gadolinium DTPA; Humans; Methylmethacrylate; Methylmethacrylates; Neoplasms; Neutron Capture Therapy; Particle Size; Stearic Acids | 1997 |
MRI of extracranial masses in children: the usefulness of gadolinium-chelate enhancement.
Topics: Child, Preschool; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Neoplasms; Retrospective Studies | 1998 |
Enhanced MRI fills in soft tissue features.
Topics: Contrast Media; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms; Pentetic Acid | 1991 |
Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.
Topics: Carbohydrate Sequence; Chitin; Chitosan; Contrast Media; Dealkylation; Emulsions; Gadolinium; Gadolinium DTPA; Gamma Rays; Microspheres; Molecular Sequence Data; Neoplasms; Neutron Capture Therapy; Particle Size; Radioisotopes | 1999 |
Non-covalent conjugates between cationic polyamino acids and GdIII chelates: a route for seeking accumulation of MRI-contrast agents at tumor targeting sites.
Topics: Chelating Agents; Contrast Media; Europium; Gadolinium; Ligands; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Metals, Rare Earth; Neoplasms; Peptides; Polyamines; Polyelectrolytes; Static Electricity; Water; Ytterbium | 2000 |
Electron and photon spectra for three gadolinium-based cancer therapy approaches.
Topics: Adult; DNA, Neoplasm; Electrons; Gadolinium; Humans; Isotopes; Monte Carlo Method; Neoplasms; Neutron Capture Therapy; Photons; Radiation Dosage; Spectrum Analysis | 2000 |
Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors.
Topics: Algorithms; Brain Neoplasms; Contrast Media; Gadolinium; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Neoplasms; Prostatic Neoplasms; Reproducibility of Results; Tissue Distribution | 2001 |
In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.
Topics: Animals; Biocompatible Materials; Chitin; Chitosan; Gadolinium; Gadolinium DTPA; L Cells; Melanoma, Experimental; Mice; Nanotechnology; Neoplasms; Neutron Capture Therapy; Tumor Cells, Cultured | 2002 |
Trace determination of gadolinium in biomedical samples by diode laser-based multi-step resonance ionization mass spectrometry.
Topics: Animals; Contrast Media; Gadolinium; Isotopes; Lasers; Magnetic Resonance Imaging; Mass Spectrometry; Mice; Mice, Nude; Neoplasms; Organ Specificity; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Transport calculations of depth-dose distributions for gadolinium neutron capture therapy.
Topics: Gadolinium; Gamma Rays; Humans; Models, Structural; Neoplasms; Neutrons; Radiotherapy Dosage; Water | 1992 |
[Contrasts in the FLASH sequences in the study of musculoskeletal tumors: phantom study and theoretical calculations].
Topics: Bone Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Models, Structural; Muscular Diseases; Musculoskeletal System; Neoplasms; Organometallic Compounds; Pentetic Acid; Time Factors | 1991 |
[Gadolinium-DTPA in magnetic resonance tomography. Clinical use--indications].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Child; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms | 1989 |